The significant role of amino acid metabolic reprogramming in cancer

Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor c...

Full description

Saved in:
Bibliographic Details
Published inCell communication and signaling Vol. 22; no. 1; pp. 380 - 26
Main Authors Liu, Xiaohong, Ren, Bo, Ren, Jie, Gu, Minzhi, You, Lei, Zhao, Yupei
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 29.07.2024
BioMed Central
BMC
Subjects
Adenosine
Amino acid metabolism
Amino acids
Amino Acids - metabolism
Analysis
Angiogenesis
Animals
Apoptosis
Biology
Biosynthesis
Cancer
Cancer therapies
Carbon
Care and treatment
Cell growth
Cellular Reprogramming
Colorectal cancer
Dehydrogenases
Development and progression
Diagnosis
Drug resistance
Enzymes
Epigenetic inheritance
Epigenetic regulation
Epigenetics
Extracellular matrix
Health aspects
Homeostasis
Humans
Immune response
Immune tolerance
Immunological tolerance
Immunomodulation
Kinases
Medical prognosis
Metabolic Reprogramming
Metabolism
Metabolites
Metastases
Metastasis
Neoplasms - metabolism
Neoplasms - pathology
Nitrogen
Oxidative metabolism
Oxidative stress
Phosphorylation
Physiological aspects
Polyamines
Protein biosynthesis
Protein synthesis
Protein turnover
Proteins
Redox
Review
Stromal cells
Tumor cells
Tumor Microenvironment
Tumors
China
Redox
Angiogenesis
Epigenetic regulation
Tumor microenvironment
Amino acid metabolism
Immune tolerance
Online AccessGet full text

Cover

Abstract Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor cell metabolism, maintenance of oxidative stress homeostasis, and epigenetic modifications. Furthermore, the dysregulation of amino acid metabolism also impacts tumor microenvironment and tumor immunity. Amino acids can act as signaling molecules that modulate immune cell function and immune tolerance within the tumor microenvironment, reshaping the anti-tumor immune response and promoting immune evasion by cancer cells. Moreover, amino acid metabolism can influence the behavior of stromal cells, such as cancer-associated fibroblasts, regulate ECM remodeling and promote angiogenesis, thereby facilitating tumor growth and metastasis. Understanding the intricate interplay between amino acid metabolism and the tumor microenvironment is of crucial significance. Expanding our knowledge of the multifaceted roles of amino acid metabolism in tumor microenvironment holds significant promise for the development of more effective cancer therapies aimed at disrupting the metabolic dependencies of cancer cells and modulating the tumor microenvironment to enhance anti-tumor immune responses and inhibit tumor progression.
AbstractList Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor cell metabolism, maintenance of oxidative stress homeostasis, and epigenetic modifications. Furthermore, the dysregulation of amino acid metabolism also impacts tumor microenvironment and tumor immunity. Amino acids can act as signaling molecules that modulate immune cell function and immune tolerance within the tumor microenvironment, reshaping the anti-tumor immune response and promoting immune evasion by cancer cells. Moreover, amino acid metabolism can influence the behavior of stromal cells, such as cancer-associated fibroblasts, regulate ECM remodeling and promote angiogenesis, thereby facilitating tumor growth and metastasis. Understanding the intricate interplay between amino acid metabolism and the tumor microenvironment is of crucial significance. Expanding our knowledge of the multifaceted roles of amino acid metabolism in tumor microenvironment holds significant promise for the development of more effective cancer therapies aimed at disrupting the metabolic dependencies of cancer cells and modulating the tumor microenvironment to enhance anti-tumor immune responses and inhibit tumor progression.
Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor cell metabolism, maintenance of oxidative stress homeostasis, and epigenetic modifications. Furthermore, the dysregulation of amino acid metabolism also impacts tumor microenvironment and tumor immunity. Amino acids can act as signaling molecules that modulate immune cell function and immune tolerance within the tumor microenvironment, reshaping the anti-tumor immune response and promoting immune evasion by cancer cells. Moreover, amino acid metabolism can influence the behavior of stromal cells, such as cancer-associated fibroblasts, regulate ECM remodeling and promote angiogenesis, thereby facilitating tumor growth and metastasis. Understanding the intricate interplay between amino acid metabolism and the tumor microenvironment is of crucial significance. Expanding our knowledge of the multifaceted roles of amino acid metabolism in tumor microenvironment holds significant promise for the development of more effective cancer therapies aimed at disrupting the metabolic dependencies of cancer cells and modulating the tumor microenvironment to enhance anti-tumor immune responses and inhibit tumor progression.Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor cell metabolism, maintenance of oxidative stress homeostasis, and epigenetic modifications. Furthermore, the dysregulation of amino acid metabolism also impacts tumor microenvironment and tumor immunity. Amino acids can act as signaling molecules that modulate immune cell function and immune tolerance within the tumor microenvironment, reshaping the anti-tumor immune response and promoting immune evasion by cancer cells. Moreover, amino acid metabolism can influence the behavior of stromal cells, such as cancer-associated fibroblasts, regulate ECM remodeling and promote angiogenesis, thereby facilitating tumor growth and metastasis. Understanding the intricate interplay between amino acid metabolism and the tumor microenvironment is of crucial significance. Expanding our knowledge of the multifaceted roles of amino acid metabolism in tumor microenvironment holds significant promise for the development of more effective cancer therapies aimed at disrupting the metabolic dependencies of cancer cells and modulating the tumor microenvironment to enhance anti-tumor immune responses and inhibit tumor progression.
Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor cell metabolism, maintenance of oxidative stress homeostasis, and epigenetic modifications. Furthermore, the dysregulation of amino acid metabolism also impacts tumor microenvironment and tumor immunity. Amino acids can act as signaling molecules that modulate immune cell function and immune tolerance within the tumor microenvironment, reshaping the anti-tumor immune response and promoting immune evasion by cancer cells. Moreover, amino acid metabolism can influence the behavior of stromal cells, such as cancer-associated fibroblasts, regulate ECM remodeling and promote angiogenesis, thereby facilitating tumor growth and metastasis. Understanding the intricate interplay between amino acid metabolism and the tumor microenvironment is of crucial significance. Expanding our knowledge of the multifaceted roles of amino acid metabolism in tumor microenvironment holds significant promise for the development of more effective cancer therapies aimed at disrupting the metabolic dependencies of cancer cells and modulating the tumor microenvironment to enhance anti-tumor immune responses and inhibit tumor progression. Keywords: Amino acid metabolism, Tumor microenvironment, Redox, Epigenetic regulation, Immune tolerance, Angiogenesis
Abstract Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino acids in tumor cells is intricately linked to protein synthesis, nucleotide synthesis, modulation of signaling pathways, regulation of tumor cell metabolism, maintenance of oxidative stress homeostasis, and epigenetic modifications. Furthermore, the dysregulation of amino acid metabolism also impacts tumor microenvironment and tumor immunity. Amino acids can act as signaling molecules that modulate immune cell function and immune tolerance within the tumor microenvironment, reshaping the anti-tumor immune response and promoting immune evasion by cancer cells. Moreover, amino acid metabolism can influence the behavior of stromal cells, such as cancer-associated fibroblasts, regulate ECM remodeling and promote angiogenesis, thereby facilitating tumor growth and metastasis. Understanding the intricate interplay between amino acid metabolism and the tumor microenvironment is of crucial significance. Expanding our knowledge of the multifaceted roles of amino acid metabolism in tumor microenvironment holds significant promise for the development of more effective cancer therapies aimed at disrupting the metabolic dependencies of cancer cells and modulating the tumor microenvironment to enhance anti-tumor immune responses and inhibit tumor progression.
ArticleNumber 380
Audience Academic
Author Ren, Jie
You, Lei
Gu, Minzhi
Liu, Xiaohong
Ren, Bo
Zhao, Yupei
Author_xml – sequence: 1
  givenname: Xiaohong
  surname: Liu
  fullname: Liu, Xiaohong
– sequence: 2
  givenname: Bo
  surname: Ren
  fullname: Ren, Bo
– sequence: 3
  givenname: Jie
  surname: Ren
  fullname: Ren, Jie
– sequence: 4
  givenname: Minzhi
  surname: Gu
  fullname: Gu, Minzhi
– sequence: 5
  givenname: Lei
  surname: You
  fullname: You, Lei
– sequence: 6
  givenname: Yupei
  surname: Zhao
  fullname: Zhao, Yupei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39069612$$D View this record in MEDLINE/PubMed
BookMark eNp9kltrFTEUhQep2Iv-AR9kwJf6MDW3ySRPUurtQEHQCr6FTLIzzWEmOSYzov_enJ5ae4pICAk731ohO-u4OggxQFU9x-gMY8FfZ0wkZw0iZeKOowY_qo4w60QjMP52cG9_WB3nvEaFbFn3pDqkEnHJMTmq3l5dQ539ELzzRoe5TnGEOrpaTz7EWhtv6wlm3cfRmzrBJsUh6akcDrUPdZEYSE-rx06PGZ7drifV1_fvri4-NpefPqwuzi8b00oxN2CppNwaxkjXto5QDlK2ViPdM6ZFByCgp9QiS3uJhXQ94h0YiZzVBElLT6rVztdGvVab5CedfqmovbopxDQonWZvRlCyQy1CnWBIEGa41tIKaxDBTiCngRevNzuvzdJPYA2EOelxz3T_JPhrNcQfCmMiWkZIcTi9dUjx-wJ5VpPPBsZRB4hLVhSJlgvOES3oywfoOi4plF4VSpZvpJ2Uf6lBlxf44GK52GxN1blARDLMJSvU2T-oMixM3pSEOF_qe4JXe4LCzPBzHvSSs1p9-bzPvrjflbt2_AlMAcgOMCnmnMDdIRipbSrVLpWqZE3dpFLhIhIPRMbPevZx21k__k_6Gxmj4xg
CitedBy_id crossref_primary_10_1016_j_microc_2024_111687
crossref_primary_10_3389_fphar_2024_1450441
crossref_primary_10_3892_ol_2025_14950
crossref_primary_10_3390_cancers17010054
crossref_primary_10_1039_D4NR03454F
crossref_primary_10_1186_s43556_024_00229_4
crossref_primary_10_1016_j_bbalip_2025_159593
crossref_primary_10_3389_fgene_2024_1521269
crossref_primary_10_1016_j_bbcan_2025_189263
crossref_primary_10_1080_10715762_2024_2423690
crossref_primary_10_1016_j_jconrel_2025_01_072
crossref_primary_10_1016_j_drup_2025_101238
Cites_doi 10.1016/j.immuni.2022.01.006
10.1039/D2BM01456D
10.1186/s12951-022-01424-7
10.3233/CBM-220421
10.1084/jem.137.5.1142
10.1038/s41467-020-18570-x
10.1016/j.bbcan.2019.05.006
10.1038/nm.3856
10.1016/j.cmet.2020.06.010
10.2147/JIR.S383623
10.1038/s41568-022-00473-2
10.1073/pnas.1204176109
10.3390/ijms23074022
10.1016/j.jtha.2023.06.039
10.1096/fasebj.5.11.1907934
10.1038/s41571-019-0175-7
10.1002/dmr.5610050303
10.1038/nm934
10.1038/nature20165
10.1371/journal.pgen.1002573
10.1016/j.apsb.2021.07.016
10.1038/s43018-024-00739-8
10.1016/j.semcancer.2019.07.003
10.1152/ajpendo.00208.2001
10.1016/j.bbrc.2012.07.139
10.7554/eLife.80721
10.1038/s41586-021-04082-1
10.1016/j.vph.2018.11.001
10.1093/jn/130.10.2413
10.1146/annurev.immunol.15.1.323
10.1038/s43018-022-00411-z
10.1016/j.tcb.2023.05.001
10.1038/s41590-020-0700-y
10.15252/embj.201695518
10.1038/s41556-018-0118-z
10.1080/15548627.2022.2062875
10.1038/s42255-022-00582-0
10.1038/s41416-019-0620-5
10.1038/nm.3955
10.1146/annurev-immunol-061020-053707
10.1016/j.immuni.2019.06.007
10.1038/nrm.2017.95
10.1016/j.advms.2021.12.005
10.1038/s41467-021-21804-1
10.1016/S1567-5688(03)00034-5
10.1016/j.cmet.2021.05.009
10.3390/genes8030088
10.3892/or.2016.4660
10.1016/j.gendis.2020.11.010
10.1158/0008-5472.CAN-22-1837
10.7150/ijbs.72534
10.1038/s41586-020-2682-1
10.1016/j.nut.2009.12.008
10.1016/j.redox.2023.102696
10.1016/j.isci.2018.03.012
10.1182/bloodadvances.2022008272
10.1038/s41467-020-15573-6
10.1016/j.cmet.2018.06.009
10.1016/j.cell.2021.05.027
10.1042/BSR20221682
10.3390/cells11010140
10.1038/ncb1807
10.1016/j.coph.2017.05.004
10.1172/JCI131859
10.1177/0148607195019006477
10.1016/j.arr.2022.101573
10.1038/onc.2009.358
10.1248/bpb.b18-00055
10.1093/carcin/20.5.793
10.1038/s41467-022-30363-y
10.1128/MCB.00946-13
10.1111/j.1476-5381.2009.00278.x
10.7554/eLife.10250
10.1152/physrev.00012.2018
10.1016/0014-4827(88)90328-X
10.1002/ijc.34353
10.1002/eji.1830050208
10.3390/cells10010124
10.3390/polym13111813
10.1038/s41423-022-00925-7
10.3390/cells10030563
10.1080/19336918.2018.1540903
10.1186/1756-9966-30-95
10.1038/s41467-017-00489-5
10.32471/exp-oncology.2312-8852.vol-42-no-4.15401
10.3892/or.2023.8496
10.1016/j.celrep.2022.110320
10.1016/0008-8749(90)90184-S
10.1038/s41556-021-00820-9
10.1136/jitc-2021-003149
10.1016/j.cmet.2021.02.001
10.1126/sciadv.add6995
10.1016/j.immuni.2017.01.005
10.1016/j.yexcr.2013.04.005
10.1016/j.immuni.2018.09.009
10.1016/j.freeradbiomed.2014.11.012
10.1038/s41590-020-0666-9
10.1016/j.ccell.2016.10.006
10.1097/MCO.0b013e32834de431
10.1016/j.molmet.2018.08.002
10.1158/1541-7786.MCR-19-0018
10.1007/s13238-020-00789-5
10.1038/s41467-022-34064-4
10.1080/2162402X.2022.2055703
10.1016/j.cell.2021.06.007
10.1189/jlb.1HI0216-062RR
10.3390/cancers15030623
10.1016/j.ijsu.2021.106051
10.1016/j.canlet.2018.05.005
10.1038/s41586-023-06256-5
10.1016/j.jri.2020.103270
10.1016/j.currproblcancer.2019.05.005
10.1006/excr.2001.5177
10.1158/0008-5472.CAN-05-0623
10.1038/s41392-022-01017-8
10.1038/s41419-019-1463-y
10.1016/j.celrep.2023.112186
10.1158/2159-8290.CD-20-1808
10.1001/jamaoncol.2017.1617
10.1186/s13046-023-02845-4
10.1021/acsnano.2c11280
10.1515/revneuro-2022-0047
10.1016/j.cell.2014.11.034
10.1016/j.biomaterials.2022.121938
10.1016/j.jaci.2020.04.037
10.1038/s41556-020-00615-4
10.1016/j.ebiom.2016.11.013
10.1126/science.aaw5473
10.1016/j.immuni.2011.09.021
10.1038/s41388-020-1262-z
10.1016/j.cell.2021.05.045
10.1007/s007260170065
10.1096/fj.201802842RR
10.1038/s41556-023-01091-2
10.1007/s00726-007-0560-x
10.1016/j.bbagen.2017.01.014
10.1158/1535-7163.MCT-18-1323
10.1152/ajpcell.00169.2023
10.1007/s00018-008-8295-8
10.1016/j.immuni.2015.02.005
10.1038/nm.3394
10.1021/acscentsci.3c00702
10.1152/ajpendo.2001.280.1.E75
10.1182/blood-2004-05-1726
10.1172/JCI31911
10.1038/s41467-023-39401-9
10.4049/jimmunol.164.6.3283
10.1038/s41556-020-0496-x
10.1111/febs.16803
10.1016/j.bbrc.2003.07.019
10.1038/nature11540
10.1038/s41586-023-05891-2
10.1016/bs.ircmb.2022.08.001
10.1038/s41580-019-0123-5
10.1016/j.cmet.2016.12.011
10.1038/s12276-020-0375-3
10.1038/s41467-023-39571-6
10.1016/j.tcb.2023.08.002
10.3390/antiox8050112
10.1016/j.tcb.2022.09.002
10.1038/ni.3796
10.1021/acsnano.2c02605
10.1038/onc.2010.51
10.1016/j.xcrm.2023.100941
10.1016/j.coi.2005.11.008
10.1016/j.cell.2023.03.011
10.1016/j.smim.2003.12.005
10.1016/j.cell.2018.03.001
10.3390/molecules28020862
10.1016/j.intimp.2016.03.002
10.1038/s41586-019-1170-y
10.1016/j.ceb.2023.102218
10.7554/eLife.36158
10.3389/fimmu.2020.616367
10.2174/157016112798829760
10.1016/j.molcel.2021.04.002
10.1016/j.cmet.2019.08.011
10.1038/s41419-020-2298-2
10.1038/s41388-023-02632-7
10.1074/jbc.M112.392225
10.1038/s41419-022-05448-7
10.15698/cst2023.07.281
10.1038/sj.onc.1204792
10.3390/cancers13143541
10.1016/j.semcancer.2006.10.009
10.1038/s41467-018-04719-2
10.1073/pnas.1804932115
10.1128/spectrum.02759-22
10.1080/14397595.2018.1510822
10.1038/cdd.2015.93
10.1038/nri2487
10.1126/scitranslmed.add7900
10.3390/biom11111666
10.1016/j.cmet.2022.08.008
10.15252/embr.201439246
10.1016/j.molcel.2012.11.006
10.15252/embj.2019103334
10.1038/nrc.2016.81
10.3389/fonc.2023.1256769
10.1016/j.cmet.2020.01.006
10.1158/2159-8290.CD-12-0014
10.1038/s41573-019-0016-5
10.1038/s42255-023-00856-1
10.1038/s41556-018-0083-6
10.1038/s41589-019-0462-8
10.1016/j.molcel.2012.05.043
10.1016/S0021-9258(18)47947-1
10.1038/nri1668
10.1016/j.molcel.2021.03.009
10.1016/j.cmet.2016.10.011
10.1038/ni1003
10.3174/ajnr.A7762
10.4049/jimmunol.160.11.5347
10.2174/138920311795659407
10.1038/s12276-021-00613-y
10.7150/ijbs.95484
10.1038/s41576-020-0262-8
10.1038/s41388-023-02868-3
10.1007/s11010-016-2843-6
10.1016/j.cmet.2012.06.001
10.1016/j.redox.2023.102641
10.1038/s41586-018-0597-x
10.1039/D3BM90029K
10.1016/j.cmet.2017.06.010
10.4049/jimmunol.1201449
10.1186/s13046-023-02629-w
10.1038/s41568-019-0149-1
10.1038/nature13236
10.1016/j.cell.2021.02.021
10.1007/BF01733887
10.1016/j.molcel.2012.09.017
10.7554/eLife.72593
10.1016/j.gde.2005.08.002
10.1016/j.ccell.2019.12.011
10.3390/medicina56010015
10.1126/sciadv.aar2606
10.1016/0008-8749(87)90060-8
10.1038/s41419-022-05384-6
10.1038/ni.2556
10.1016/j.devcel.2021.05.011
10.1016/j.immuni.2014.04.007
10.1016/j.tips.2018.10.008
10.1021/acsnano.2c11037
10.1146/annurev-pathmechdis-012418-012718
10.2967/jnumed.122.264859
10.1016/j.molcel.2023.11.042
10.1016/j.molcel.2019.06.039
10.1016/j.molcel.2024.01.002
10.1158/0008-5472.CAN-09-2587
10.1016/j.freeradbiomed.2020.12.002
10.1158/0008-5472.CAN-15-1490
10.1101/gad.327056.119
10.4049/jimmunol.1700497
10.1126/science.aao3265
10.1126/sciadv.abe2771
10.1111/cas.13827
10.1038/s12276-020-00504-8
10.1038/s41577-019-0210-z
10.1016/j.cellimm.2020.104119
10.1038/s42255-021-00471-y
10.1038/s41581-022-00648-y
10.1016/j.canlet.2023.216120
10.1038/s41568-018-0050-3
10.1038/s41598-017-15246-3
10.1186/s13046-020-01709-5
10.1038/s41467-022-30362-z
10.1136/gutjnl-2022-326928
10.1038/35069118
10.3389/fendo.2022.988295
10.1093/jn/134.3.489
10.1038/s41586-021-03768-w
10.1038/s42255-022-00558-0
10.1016/j.cell.2024.02.005
10.1093/infdis/jiu115
10.1074/jbc.M110675200
10.1158/2326-6066.CIR-19-0041
10.1038/s41586-018-0701-2
10.1111/jth.13951
10.1016/j.cmet.2022.12.003
10.1038/sj.bjc.6604485
10.1016/j.cmet.2017.12.007
10.1038/s41586-023-06299-8
10.18632/oncotarget.6311
10.1136/jitc-2020-001532
10.1038/nrc.2016.71
10.1016/j.cmet.2020.03.004
10.1002/cam4.6484
10.1007/s13346-023-01323-w
10.1038/s41422-018-0021-y
10.1016/j.tibs.2014.02.004
10.1038/ncomms1676
10.26508/lsa.202201663
10.1016/j.colsurfb.2023.113232
10.3389/fimmu.2023.1133308
10.1073/pnas.1818521116
10.1038/nri778
10.1097/HJH.0b013e328312c8a3
10.1016/j.cell.2017.02.004
10.1038/s42255-021-00412-9
10.1016/j.immuni.2021.09.005
10.1186/s13045-023-01453-1
10.1038/s41577-019-0127-6
10.1074/jbc.RA118.005892
10.1016/j.cmet.2019.01.014
10.1016/j.cell.2021.04.001
10.2337/diabetes.50.2.353
10.1016/j.arr.2023.102066
10.1002/hep.31875
10.1186/s40425-019-0725-7
10.1158/2326-6066.CIR-20-0226
10.1038/386671a0
10.1016/j.cmet.2018.09.012
10.1177/11786469231185102
10.1016/j.cmet.2015.12.006
10.1083/jcb.200703099
10.1097/SLA.0b013e31828611f8
10.15252/embj.201796436
10.1146/annurev-physiol-020518-114455
10.1158/0008-5472.CAN-22-3042
10.1002/adma.202211370
10.1038/s41556-019-0408-0
10.1038/ni.3439
10.1002/eji.201546047
10.1038/s41590-018-0255-3
10.1016/j.celrep.2021.109235
10.15252/embr.202051239
10.3389/fonc.2020.614230
10.1016/j.tcb.2020.09.010
10.1158/0008-5472.CAN-06-3037
10.3389/fimmu.2020.01866
10.1016/j.cell.2013.12.010
10.1053/j.gastro.2022.11.014
10.1038/s42255-020-00315-1
10.1016/j.pharmthera.2020.107746
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QP
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOA
DOI 10.1186/s12964-024-01760-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central Database Suite (ProQuest)
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database (ProQuest)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1478-811X
EndPage 26
ExternalDocumentID oai_doaj_org_article_9705007840824c6aa9d8dc021f80fae6
PMC11285422
A802941694
39069612
10_1186_s12964_024_01760_1
Genre Journal Article
Review
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases
  grantid: Z190022
– fundername: Non-proft Central Research Institute Fund of Chinese Academy of Medical Sciences
  grantid: No. 2018PT32014
– fundername: CAMS Innovation Fund for Medical Sciences (CIFMS)
  grantid: 2021-I2M-1-002 to Y. Z.
– fundername: National Natural Science Foundation of China
  grantid: 81972321 and 82273455 L. Y., 82303504 to B.R.
– fundername: National High Level Hospital Clinical Research Funding
  grantid: No. 2022-PUMCH-D-001
GroupedDBID ---
0R~
29B
2WC
53G
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
PMFND
3V.
7QP
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c598t-ed3936dc442755f236e995da0ab44a87ee8eb33d0d3b9189fb067ec90fda209d3
IEDL.DBID M48
ISSN 1478-811X
IngestDate Wed Aug 27 01:29:54 EDT 2025
Thu Aug 21 18:34:02 EDT 2025
Fri Jul 11 00:02:00 EDT 2025
Fri Jul 25 19:33:52 EDT 2025
Tue Jun 17 22:07:40 EDT 2025
Tue Jun 10 21:04:44 EDT 2025
Fri Jun 27 05:53:36 EDT 2025
Mon Jul 21 05:44:23 EDT 2025
Thu Apr 24 22:52:43 EDT 2025
Tue Jul 01 00:59:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Redox
Angiogenesis
Epigenetic regulation
Tumor microenvironment
Amino acid metabolism
Immune tolerance
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c598t-ed3936dc442755f236e995da0ab44a87ee8eb33d0d3b9189fb067ec90fda209d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/3091293799?pq-origsite=%requestingapplication%
PMID 39069612
PQID 3091293799
PQPubID 40257
PageCount 26
ParticipantIDs doaj_primary_oai_doaj_org_article_9705007840824c6aa9d8dc021f80fae6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11285422
proquest_miscellaneous_3085686603
proquest_journals_3091293799
gale_infotracmisc_A802941694
gale_infotracacademiconefile_A802941694
gale_incontextgauss_ISR_A802941694
pubmed_primary_39069612
crossref_primary_10_1186_s12964_024_01760_1
crossref_citationtrail_10_1186_s12964_024_01760_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-29
PublicationDateYYYYMMDD 2024-07-29
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-29
  day: 29
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Cell communication and signaling
PublicationTitleAlternate Cell Commun Signal
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References I Amelio (1760_CR69) 2014; 39
C Tokunaga (1760_CR42) 2004; 313
MH Hung (1760_CR132) 2021; 12
MB Nilsson (1760_CR272) 2005; 65
MJ Bender (1760_CR148) 2023; 186
X Dong (1760_CR330) 2023; 9
DG Ryan (1760_CR7) 2021; 10
N Kiweler (1760_CR38) 2022; 13
LA Naleskina (1760_CR16) 2020; 42
M Torigoe (1760_CR184) 2019; 29
MC Bosco (1760_CR199) 2000; 164
JP Cooke (1760_CR268) 2003; 4
1760_CR14
J Yu (1760_CR232) 2013; 190
IT Helenius (1760_CR98) 2021; 11
MD Sharma (1760_CR227) 2021; 54
H Gmünder (1760_CR133) 1990; 129
X Huang (1760_CR147) 2023; 83
CE Holbert (1760_CR158) 2022; 22
C Wang (1760_CR212) 2024; 84
BR McAuslan (1760_CR271) 1988; 176
A Shadboorestan (1760_CR314) 2023; 16
LM Castell (1760_CR216) 2001; 20
A Stiff (1760_CR226) 2016; 76
G Mondanelli (1760_CR228) 2017; 46
Y Cao (1760_CR294) 2016; 35
N Galldiks (1760_CR340) 2023; 64
RA Saxton (1760_CR50) 2017; 168
S Vandekeere (1760_CR261) 2018; 28
W Ma (1760_CR119) 2024; 84
S Pan (1760_CR183) 2023; 35
T Bertero (1760_CR283) 2019; 29
M Yuneva (1760_CR61) 2007; 178
T Baumann (1760_CR153) 2020; 21
Y Yuan (1760_CR17) 2016; 35
Q Zhou (1760_CR234) 2023; 14
ES Arnér (1760_CR95) 2006; 16
V Bronte (1760_CR231) 2005; 5
L Safrhansova (1760_CR4) 2022; 373
HC Yoo (1760_CR13) 2022; 11
CB Wilson (1760_CR159) 2009; 9
JC Black (1760_CR107) 2012; 48
R Bertolio (1760_CR285) 2023; 84
Y Tang (1760_CR335) 2022; 20
JNR Gnanaprakasam (1760_CR165) 2023; 5
M Yang (1760_CR36) 2016; 16
AE Rodriguez (1760_CR210) 2019; 29
DA Hume (1760_CR190) 2006; 18
YP Kang (1760_CR250) 2019; 8
JC Anthony (1760_CR31) 2000; 130
CC Yao (1760_CR161) 2023; 42
RC Mishra (1760_CR263) 2008; 26
S Phuyal (1760_CR279) 2023; 33
S Torrino (1760_CR284) 2021; 33
AA Badawy (1760_CR73) 2022; 42
EL Lieu (1760_CR116) 2020; 52
X Li (1760_CR8) 2023; 291
A Del Prete (1760_CR15) 2017; 35
N Morikawa (1760_CR304) 2018; 41
J Li (1760_CR247) 2020; 11
J Brosnan (1760_CR28) 2012; 15
J MacMicking (1760_CR205) 1997; 15
AS Krall (1760_CR45) 2021; 33
H Jensen (1760_CR301) 2017; 199
C Xie (1760_CR77) 2016; 7
Z Hu (1760_CR333) 2023; 224
H Jiang (1760_CR46) 2023; 21
HC Yoo (1760_CR60) 2020; 52
S Jiang (1760_CR185) 2018; 27
C Guo (1760_CR224) 2023; 620
H Liu (1760_CR277) 2014; 34
T Han (1760_CR58) 2018; 28
CL Chen (1760_CR63) 2021; 13
SI Galkina (1760_CR217) 2021; 10
G Taurino (1760_CR251) 2023; 325
RA Casero Jr (1760_CR64) 2018; 18
X Zhou (1760_CR243) 2022; 12
LJ Castro-Muñoz (1760_CR59) 2023; 49
MW Taylor (1760_CR274) 1991; 5
RL Westbrook (1760_CR97) 2022; 38
I Chitapanarux (1760_CR293) 2020; 44
Y Yan (1760_CR93) 2023; 14
C Uyttenhove (1760_CR143) 2003; 9
PA Tyrakis (1760_CR145) 2016; 540
J Garcia-Bermudez (1760_CR288) 2018; 20
J Shi (1760_CR302) 2019; 7
JX Cui (1760_CR180) 2023; 42
H Li (1760_CR270) 2001; 280
F Fuks (1760_CR103) 2005; 15
R Guo (1760_CR187) 2022; 34
S Li (1760_CR298) 2022; 15
X Zhang (1760_CR193) 2023; 619
S Lores (1760_CR321) 2023; 11
A Dimou (1760_CR117) 2022; 23
MH Oh (1760_CR235) 2020; 130
X Jiang (1760_CR21) 2020; 39
AK Murugan (1760_CR52) 2019; 59
W Yan (1760_CR252) 2018; 20
SJF Cronin (1760_CR309) 2018; 563
M Swamy (1760_CR137) 2016; 17
AE Vaughn (1760_CR87) 2008; 10
S Sivanand (1760_CR115) 2020; 37
MK Srivastava (1760_CR134) 2010; 70
U Hainz (1760_CR142) 2005; 105
Y Wu (1760_CR214) 2024; 187
DG Roy (1760_CR131) 2020; 31
EH Ma (1760_CR160) 2017; 25
A Salminen (1760_CR70) 2022; 75
R Liang (1760_CR182) 2024; 20
S Mazurek (1760_CR83) 2001; 20
TL Bowlin (1760_CR156) 1987; 105
LM Mauracher (1760_CR125) 2018; 16
D Herranz (1760_CR76) 2015; 21
D Guo (1760_CR265) 2017; 7
CH Tsai (1760_CR22) 2023; 35
J Merlin (1760_CR203) 2021; 3
B Toubhans (1760_CR111) 2023; 61
A Mondal (1760_CR273) 2016; 14
B Faubert (1760_CR2) 2020; 368
AR Cantelmo (1760_CR262) 2016; 30
B Karno (1760_CR12) 2023; 42
S Schmidt (1760_CR303) 2019; 21
P Sittitrai (1760_CR295) 2021; 93
Y Chen (1760_CR316) 2023; 15
X Li (1760_CR257) 2019; 30
Q Yang (1760_CR328) 2022; 11
NN Pavlova (1760_CR1) 2016; 23
SL Yang (1760_CR181) 2021; 143
DF Quail (1760_CR18) 2013; 19
L Ji (1760_CR207) 2019; 51
N Majd (1760_CR306) 2020; 8
L Deng (1760_CR55) 2020; 11
SC Baksh (1760_CR146) 2021; 31
X Gong (1760_CR71) 2023; 34
W Wang (1760_CR135) 2019; 569
SM Almutairi (1760_CR178) 2019; 294
S Herzig (1760_CR54) 2018; 19
S Lores (1760_CR320) 2023; 11
WM Choi (1760_CR179) 2021; 74
W Yu (1760_CR196) 2019; 75
K Hezaveh (1760_CR200) 2022; 55
MY Fong (1760_CR253) 2021; 22
A Nyga (1760_CR280) 2023; 33
L Yang (1760_CR289) 2016; 24
Y Lee (1760_CR37) 2024; 5
HW Sun (1760_CR236) 2020; 11
J Zhu (1760_CR35) 2019; 20
K Liu (1760_CR127) 2019; 10
CF Chang (1760_CR101) 2015; 79
LJ Pallett (1760_CR230) 2015; 21
G Xu (1760_CR49) 2001; 50
Y Togashi (1760_CR167) 2019; 16
M Locati (1760_CR191) 2020; 15
N Ding (1760_CR322) 2023; 11
C Basson (1760_CR72) 2023; 12
X Liu (1760_CR90) 2021; 8
C Geng (1760_CR332) 2021; 13
E Villa (1760_CR105) 2021; 81
ME May (1760_CR30) 1989; 5
J Zang (1760_CR338) 2023; 292
RE Oberkersch (1760_CR11) 2019; 112
T Noguchi (1760_CR82) 1987; 262
H Kurniawan (1760_CR170) 2020; 31
RJ Tesi (1760_CR244) 2019; 40
R Radi (1760_CR100) 2018; 115
W Chen (1760_CR118) 2021; 3
GM Carriche (1760_CR173) 2021; 147
D Wen (1760_CR195) 2024; 39
W Sun (1760_CR67) 2023; 152
J Smestad (1760_CR120) 2018; 2
H Liang (1760_CR334) 2023; 17
Z Mai (1760_CR337) 2023; 17
M Nakaya (1760_CR141) 2014; 40
LM Dos Santos (1760_CR194) 2017; 424
C Lu (1760_CR114) 2012; 16
AK Jha (1760_CR201) 2015; 42
Y Fan (1760_CR27) 2017; 1861
JP Friedmann Angeli (1760_CR241) 2019; 19
LV Sinclair (1760_CR163) 2013; 14
GL Nelsestuen (1760_CR34) 1978; 11
Q Tian (1760_CR57) 2020; 39
R Kiessling (1760_CR175) 1975; 5
H Huang (1760_CR140) 2021; 184
PS Liu (1760_CR202) 2017; 18
A Zimmermann (1760_CR318) 2023; 7
A Arruabarrena-Aristorena (1760_CR66) 2018; 4
Y Bian (1760_CR130) 2020; 585
MH Soflaee (1760_CR40) 2022; 13
LM Nilsson (1760_CR68) 2012; 8
K Chamoto (1760_CR319) 2023; 34
N Soni (1760_CR339) 2023; 44
T Li (1760_CR106) 2023; 72
S Solanki (1760_CR53) 2023; 164
G Grasmann (1760_CR79) 2019; 1872
LV Sinclair (1760_CR129) 2019; 8
C Baecher-Allan (1760_CR166) 2004; 16
D Lavie (1760_CR23) 2022; 3
PX Liew (1760_CR213) 2019; 99
D Tousoulis (1760_CR267) 2012; 10
H Huang (1760_CR126) 2021; 7
SI Galkina (1760_CR218) 2019; 13
C Tanikawa (1760_CR123) 2012; 3
A Werner (1760_CR151) 2016; 46
P Koppula (1760_CR169) 2021; 12
M Pan (1760_CR258) 1995; 19
Z Hu (1760_CR331) 2023; 13
J Fan (1760_CR96) 2014; 510
M Cabeza-Cabrerizo (1760_CR220) 2021; 39
S Coni (1760_CR317) 2023; 559
F Fallarino (1760_CR225) 2003; 4
DI Gabrilovich (1760_CR229) 2007; 67
RV Durán (1760_CR43) 2012; 47
X Shan (1760_CR211) 2022; 19
RJ DeBerardinis (1760_CR5) 2010; 29
M Morotti (1760_CR299) 2019; 116
X Liu (1760_CR92) 2020; 22
X Liu (1760_CR91) 2023; 25
YK Zhang (1760_CR47) 2017; 8
NE Baker (1760_CR192) 2020; 21
S Nabe (1760_CR286) 2018; 109
L Shi (1760_CR122) 2020; 18
Y Adachi (1760_CR56) 2018; 17
S Dey (1760_CR275) 2021; 9
D Ternes (1760_CR39) 2022; 4
AA Kapralov (1760_CR245) 2020; 16
S Panetti (1760_CR325) 2023; 7
ML Rose (1760_CR264) 1999; 20
MK Hayward (1760_CR278) 2021; 56
A Elorza (1760_CR300) 2012; 48
GK Scott (1760_CR291) 2019; 18
RM Loftus (1760_CR177) 2018; 9
KY Lai (1760_CR102) 2021; 184
C Bodineau (1760_CR62) 2022; 18
A Wagner (1760_CR174) 2021; 184
S Raho (1760_CR99) 2020; 2
JP Bryant (1760_CR110) 2021; 10
A Li (1760_CR233) 2018; 431
I Hammami (1760_CR237) 2012; 425
J Wu (1760_CR164) 2021; 23
M Toulmonde (1760_CR171) 2018; 4
Q Peng (1760_CR223) 2020; 11
EJ Kay (1760_CR254) 2022; 4
AA van Beek (1760_CR186) 2017; 101
HA James (1760_CR33) 2017; 26
G Wu (1760_CR86) 2004; 134
Y Li (1760_CR112) 2023; 14
DJ Puleston (1760_CR157) 2021; 184
H Zhao (1760_CR9) 2016; 5
MD Sharma (1760_CR172) 2007; 117
S Tabata (1760_CR310) 2023; 42
PC Rodriguez (1760_CR152) 2002; 277
WS Yang (1760_CR248) 2014; 156
P Pandey (1760_CR323) 2023; 28
B Kim (1760_CR259) 2017; 36
J Ye (1760_CR81) 2012; 109
SM Morris Jr (1760_CR266) 2009; 157
G Lian (1760_CR138) 2018; 7
S Zhao (1760_CR208) 2023; 62
RE Menjivar (1760_CR154) 2023; 12
F Marangoni (1760_CR239) 2021; 184
LQ Fu (1760_CR25) 2020; 353
Y Zhang (1760_CR6) 2008; 65
C Chen (1760_CR19) 2023; 14
X Hu (1760_CR89) 2022; 13
T Yue (1760_CR136) 2023; 83
CC Stamper (1760_CR222) 2001; 410
Q Dang (1760_CR238) 2022; 13
V Capaci (1760_CR282) 2020; 10
JN Gnanaprakasam (1760_CR155) 2017; 8
MW Pickup (1760_CR287) 2014; 15
Q Yang (1760_CR327) 2024; S1525–0016
N Venkateswaran (1760_CR74) 2019; 33
Y Zheng (1760_CR324) 2023; 42
A Plotnikov (1760_CR108) 2020; 10
X Gu (1760_CR44) 2017; 358
PS Minhas (1760_CR198) 2019; 20
S Tanaka (1760_CR242) 2020; 21
L Bejarano (1760_CR26) 2021; 11
JC Anthony (1760_CR32) 2002; 282
H Byakwaga (1760_CR144) 2014; 210
RA León-Letelier (1760_CR313) 2023; 13
JCN Kenski (1760_CR149) 2023; 4
T Nitta (1760_CR188) 2001; 265
J Chen (1760_CR48) 2021; 596
CJ Lagranha (1760_CR215) 2008; 34
X Zhu (1760_CR150) 2014; 259
K Soda (1760_CR269) 2011; 30
L Vettore (1760_CR3) 2020; 122
DM Muoio (1760_CR80) 2014; 159
BJ Altman (1760_CR78) 2016; 16
L Yang (1760_CR204) 2023; 16
A Dolšak (1760_CR305) 2021; 221
Y Tong (1760_CR121) 2021; 81
M Platten (1760_CR197) 2019; 18
J Szefel (1760_CR296) 2022; 67
B Kelly (1760_CR329) 2020; 32
S Chen (1760_CR209) 2020; 11
RM Steinman (1760_CR219) 1973; 137
C Huynh (1760_CR311) 2023; 19
SM Kaech (1760_CR128) 2002; 2
B Chaneton (1760_CR84) 2012; 491
A Zhang (1760_CR20) 2022; 18
C Sun (1760_CR312) 2023; 9
P Li (1760_CR124) 2010; 29
ML Tomasi (1760_CR65) 2013; 319
JW Hwang (1760_CR109) 2021; 53
R Wang (1760_CR297) 2011; 35
C Giuliani (1760_CR246) 2019; 8
Y Zhu (1760_CR290) 2022; 13
W Xie (1760_CR336) 2022; 16
M Neinast (1760_CR29) 2019; 81
N Saini (1760_CR168) 2022; 5
A Crinier (1760_CR176) 2018; 49
M Lo (1760_CR88) 2008; 99
H Zhou (1760_CR51) 2011; 12
F Schramme (1760_CR307) 2020; 8
MS Lee (1760_CR315) 2023; 616
D Biswas (1760_CR41) 2019; 33
JT Li (1760_CR113) 2022; 7
DG DeNardo (1760_CR24) 2019; 19
F Coppedè (1760_CR104) 2021; 170
M Munder (1760_CR206) 1998; 160
C Smith (1760_CR276) 2012; 2
B Zhang (1760_CR189) 2021; 599
H Huang (1760_CR260) 2017; 36
SK Wculek (1760_CR221) 2020; 20
M Hayano (1760_CR249) 2016; 23
D Lapenna (1760_CR85) 2023; 92
EA Nunes (1760_CR162) 2011; 27
A Longchamp (1760_CR256) 2018; 173
ER Vander Mause (1760_CR326) 2023; 15
Z Wang (1760_CR10) 2022; 13
C Xu (1760_CR240) 2021; 35
H Qin (1760_CR308) 2021; 9
S Piccolo (1760_CR281) 2023; 4
D Huang (1760_CR75
References_xml – volume: 55
  start-page: 324
  issue: 2
  year: 2022
  ident: 1760_CR200
  publication-title: Immunity
  doi: 10.1016/j.immuni.2022.01.006
– volume: 11
  start-page: 4210
  issue: 12
  year: 2023
  ident: 1760_CR320
  publication-title: Biomaterials Sci
  doi: 10.1039/D2BM01456D
– volume: 20
  start-page: 216
  issue: 1
  year: 2022
  ident: 1760_CR335
  publication-title: J Nanobiotechnol
  doi: 10.1186/s12951-022-01424-7
– volume: 39
  start-page: 37
  issue: 1
  year: 2024
  ident: 1760_CR195
  publication-title: Cancer Biomarkers
  doi: 10.3233/CBM-220421
– volume: 137
  start-page: 1142
  issue: 5
  year: 1973
  ident: 1760_CR219
  publication-title: J Exp Med
  doi: 10.1084/jem.137.5.1142
– volume: 11
  start-page: 4835
  issue: 1
  year: 2020
  ident: 1760_CR223
  publication-title: Nat Comm
  doi: 10.1038/s41467-020-18570-x
– volume: 1872
  start-page: 24
  issue: 1
  year: 2019
  ident: 1760_CR79
  publication-title: Biochim Biophys Acta Rev Cancer
  doi: 10.1016/j.bbcan.2019.05.006
– volume: 21
  start-page: 591
  issue: 6
  year: 2015
  ident: 1760_CR230
  publication-title: Nat Med
  doi: 10.1038/nm.3856
– volume: 32
  start-page: 154
  issue: 2
  year: 2020
  ident: 1760_CR329
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2020.06.010
– volume: 15
  start-page: 6607
  year: 2022
  ident: 1760_CR298
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S383623
– volume: 22
  start-page: 467
  issue: 8
  year: 2022
  ident: 1760_CR158
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-022-00473-2
– volume: 109
  start-page: 6904
  issue: 18
  year: 2012
  ident: 1760_CR81
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1204176109
– volume: 23
  start-page: 192
  issue: 7
  year: 2022
  ident: 1760_CR117
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23074022
– volume: 21
  start-page: 3224
  issue: 11
  year: 2023
  ident: 1760_CR46
  publication-title: J Thromb Haemost
  doi: 10.1016/j.jtha.2023.06.039
– volume: 5
  start-page: 2516
  issue: 11
  year: 1991
  ident: 1760_CR274
  publication-title: FASEB J
  doi: 10.1096/fasebj.5.11.1907934
– volume: 16
  start-page: 356
  issue: 6
  year: 2019
  ident: 1760_CR167
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-019-0175-7
– volume: 5
  start-page: 227
  issue: 3
  year: 1989
  ident: 1760_CR30
  publication-title: Diabetes Metabol Rev
  doi: 10.1002/dmr.5610050303
– volume: 9
  start-page: 1269
  issue: 10
  year: 2003
  ident: 1760_CR143
  publication-title: Nat Med
  doi: 10.1038/nm934
– volume: 540
  start-page: 236
  issue: 7632
  year: 2016
  ident: 1760_CR145
  publication-title: Nature
  doi: 10.1038/nature20165
– volume: 8
  start-page: e1002573
  issue: 3
  year: 2012
  ident: 1760_CR68
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1002573
– volume: 12
  start-page: 692
  issue: 2
  year: 2022
  ident: 1760_CR243
  publication-title: Acta Pharmaceutica Sinica B
  doi: 10.1016/j.apsb.2021.07.016
– volume: 5
  start-page: 701
  issue: 5
  year: 2024
  ident: 1760_CR37
  publication-title: Nat Cancer
  doi: 10.1038/s43018-024-00739-8
– volume: 59
  start-page: 92
  year: 2019
  ident: 1760_CR52
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2019.07.003
– volume: 282
  start-page: E1092
  issue: 5
  year: 2002
  ident: 1760_CR32
  publication-title: Am J Physiol Endocrinol Metabol
  doi: 10.1152/ajpendo.00208.2001
– volume: 425
  start-page: 724
  issue: 4
  year: 2012
  ident: 1760_CR237
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2012.07.139
– volume: 12
  start-page: e80721
  year: 2023
  ident: 1760_CR154
  publication-title: eLife
  doi: 10.7554/eLife.80721
– volume: 599
  start-page: 471
  issue: 7885
  year: 2021
  ident: 1760_CR189
  publication-title: Nature
  doi: 10.1038/s41586-021-04082-1
– volume: 112
  start-page: 17
  year: 2019
  ident: 1760_CR11
  publication-title: Vasc Pharmacol
  doi: 10.1016/j.vph.2018.11.001
– volume: 130
  start-page: 2413
  issue: 10
  year: 2000
  ident: 1760_CR31
  publication-title: J Nutr
  doi: 10.1093/jn/130.10.2413
– volume: 15
  start-page: 323
  year: 1997
  ident: 1760_CR205
  publication-title: Ann Rev Immunol
  doi: 10.1146/annurev.immunol.15.1.323
– volume: 3
  start-page: 793
  issue: 7
  year: 2022
  ident: 1760_CR23
  publication-title: Nat Cancer
  doi: 10.1038/s43018-022-00411-z
– volume: 33
  start-page: 1049
  issue: 12
  year: 2023
  ident: 1760_CR279
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2023.05.001
– volume: 21
  start-page: 950
  issue: 8
  year: 2020
  ident: 1760_CR242
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0700-y
– volume: 36
  start-page: 2334
  issue: 16
  year: 2017
  ident: 1760_CR260
  publication-title: EMBO J
  doi: 10.15252/embj.201695518
– volume: 20
  start-page: 775
  issue: 7
  year: 2018
  ident: 1760_CR288
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-018-0118-z
– volume: 18
  start-page: 2749
  issue: 11
  year: 2022
  ident: 1760_CR62
  publication-title: Autophagy
  doi: 10.1080/15548627.2022.2062875
– volume: 4
  start-page: 693
  issue: 6
  year: 2022
  ident: 1760_CR254
  publication-title: Nat Metabol
  doi: 10.1038/s42255-022-00582-0
– volume: 122
  start-page: 150
  issue: 2
  year: 2020
  ident: 1760_CR3
  publication-title: Brit J Cancer
  doi: 10.1038/s41416-019-0620-5
– volume: 21
  start-page: 1182
  issue: 10
  year: 2015
  ident: 1760_CR76
  publication-title: Nat Med
  doi: 10.1038/nm.3955
– volume: 39
  start-page: 131
  year: 2021
  ident: 1760_CR220
  publication-title: Ann Rev Immunol
  doi: 10.1146/annurev-immunol-061020-053707
– volume: 51
  start-page: 272
  issue: 2
  year: 2019
  ident: 1760_CR207
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.06.007
– volume: 19
  start-page: 121
  issue: 2
  year: 2018
  ident: 1760_CR54
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2017.95
– volume: 67
  start-page: 66
  issue: 1
  year: 2022
  ident: 1760_CR296
  publication-title: Adv Med Sci
  doi: 10.1016/j.advms.2021.12.005
– volume: 12
  start-page: 1455
  issue: 1
  year: 2021
  ident: 1760_CR132
  publication-title: Nat Comm
  doi: 10.1038/s41467-021-21804-1
– volume: 4
  start-page: 53
  issue: 4
  year: 2003
  ident: 1760_CR268
  publication-title: Atherosclerosis Supplements
  doi: 10.1016/S1567-5688(03)00034-5
– volume: 33
  start-page: 1342
  issue: 7
  year: 2021
  ident: 1760_CR284
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2021.05.009
– volume: 8
  start-page: 88
  issue: 3
  year: 2017
  ident: 1760_CR155
  publication-title: Genes
  doi: 10.3390/genes8030088
– volume: 35
  start-page: 2499
  issue: 5
  year: 2016
  ident: 1760_CR17
  publication-title: Oncol Rep
  doi: 10.3892/or.2016.4660
– volume: 8
  start-page: 731
  issue: 6
  year: 2021
  ident: 1760_CR90
  publication-title: Genes Dis
  doi: 10.1016/j.gendis.2020.11.010
– volume: 83
  start-page: 595
  issue: 4
  year: 2023
  ident: 1760_CR136
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-22-1837
– volume: 18
  start-page: 3019
  issue: 7
  year: 2022
  ident: 1760_CR20
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.72534
– volume: 585
  start-page: 277
  issue: 7824
  year: 2020
  ident: 1760_CR130
  publication-title: Nature
  doi: 10.1038/s41586-020-2682-1
– volume: 27
  start-page: 92
  issue: 1
  year: 2011
  ident: 1760_CR162
  publication-title: Nutrition
  doi: 10.1016/j.nut.2009.12.008
– volume: 62
  start-page: 102696
  year: 2023
  ident: 1760_CR208
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2023.102696
– volume: 2
  start-page: 63
  year: 2018
  ident: 1760_CR120
  publication-title: iScience
  doi: 10.1016/j.isci.2018.03.012
– volume: 7
  start-page: 1754
  issue: 9
  year: 2023
  ident: 1760_CR325
  publication-title: Blood Adv
  doi: 10.1182/bloodadvances.2022008272
– volume: 11
  start-page: 1755
  issue: 1
  year: 2020
  ident: 1760_CR55
  publication-title: Nat Comm
  doi: 10.1038/s41467-020-15573-6
– volume: 28
  start-page: 573
  issue: 4
  year: 2018
  ident: 1760_CR261
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2018.06.009
– volume: 184
  start-page: 3998
  issue: 15
  year: 2021
  ident: 1760_CR239
  publication-title: Cell
  doi: 10.1016/j.cell.2021.05.027
– volume: 42
  start-page: BSR20221682
  issue: 11
  year: 2022
  ident: 1760_CR73
  publication-title: Biosci Rep
  doi: 10.1042/BSR20221682
– volume: 11
  start-page: 140
  issue: 1
  year: 2022
  ident: 1760_CR13
  publication-title: Cells
  doi: 10.3390/cells11010140
– volume: 10
  start-page: 1477
  issue: 12
  year: 2008
  ident: 1760_CR87
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1807
– volume: 35
  start-page: 40
  year: 2017
  ident: 1760_CR15
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2017.05.004
– volume: 130
  start-page: 3865
  issue: 7
  year: 2020
  ident: 1760_CR235
  publication-title: J Clin Invest
  doi: 10.1172/JCI131859
– volume: 19
  start-page: 477
  issue: 6
  year: 1995
  ident: 1760_CR258
  publication-title: JPEN J Parenter Enteral Nutr
  doi: 10.1177/0148607195019006477
– volume: 75
  start-page: 101573
  year: 2022
  ident: 1760_CR70
  publication-title: Ageing Res Rev
  doi: 10.1016/j.arr.2022.101573
– volume: 29
  start-page: 313
  issue: 3
  year: 2010
  ident: 1760_CR5
  publication-title: Oncogene
  doi: 10.1038/onc.2009.358
– volume: 41
  start-page: 1866
  issue: 12
  year: 2018
  ident: 1760_CR304
  publication-title: Biol Pharm Bull
  doi: 10.1248/bpb.b18-00055
– volume: 20
  start-page: 793
  issue: 5
  year: 1999
  ident: 1760_CR264
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/20.5.793
– volume: 13
  start-page: 2699
  issue: 1
  year: 2022
  ident: 1760_CR38
  publication-title: Nat Comm
  doi: 10.1038/s41467-022-30363-y
– volume: 34
  start-page: 428
  issue: 3
  year: 2014
  ident: 1760_CR277
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00946-13
– volume: 157
  start-page: 922
  issue: 6
  year: 2009
  ident: 1760_CR266
  publication-title: Brit J Pharmacol
  doi: 10.1111/j.1476-5381.2009.00278.x
– volume: 5
  start-page: e10250
  year: 2016
  ident: 1760_CR9
  publication-title: eLife
  doi: 10.7554/eLife.10250
– volume: 99
  start-page: 1223
  issue: 2
  year: 2019
  ident: 1760_CR213
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00012.2018
– volume: 176
  start-page: 248
  issue: 2
  year: 1988
  ident: 1760_CR271
  publication-title: Exp Cell Res
  doi: 10.1016/0014-4827(88)90328-X
– volume: 152
  start-page: 2446
  issue: 12
  year: 2023
  ident: 1760_CR67
  publication-title: Int J Cancer
  doi: 10.1002/ijc.34353
– volume: 5
  start-page: 112
  issue: 2
  year: 1975
  ident: 1760_CR175
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830050208
– volume: 10
  start-page: 124
  issue: 1
  year: 2021
  ident: 1760_CR110
  publication-title: Cells
  doi: 10.3390/cells10010124
– volume: 13
  start-page: 1813
  issue: 11
  year: 2021
  ident: 1760_CR332
  publication-title: Polymers
  doi: 10.3390/polym13111813
– volume: 19
  start-page: 1263
  issue: 11
  year: 2022
  ident: 1760_CR211
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-022-00925-7
– volume: 10
  start-page: 563
  issue: 3
  year: 2021
  ident: 1760_CR217
  publication-title: Cells
  doi: 10.3390/cells10030563
– volume: 13
  start-page: 98
  issue: 1
  year: 2019
  ident: 1760_CR218
  publication-title: Cell Adh Migr
  doi: 10.1080/19336918.2018.1540903
– volume: 30
  start-page: 95
  issue: 1
  year: 2011
  ident: 1760_CR269
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-30-95
– volume: 8
  start-page: 464
  issue: 1
  year: 2017
  ident: 1760_CR47
  publication-title: Nat Comm
  doi: 10.1038/s41467-017-00489-5
– volume: 42
  start-page: 252
  issue: 4
  year: 2020
  ident: 1760_CR16
  publication-title: Exp Oncol
  doi: 10.32471/exp-oncology.2312-8852.vol-42-no-4.15401
– volume: 49
  start-page: 59
  issue: 3
  year: 2023
  ident: 1760_CR59
  publication-title: Oncol Rep
  doi: 10.3892/or.2023.8496
– volume: 38
  start-page: 110320
  issue: 5
  year: 2022
  ident: 1760_CR97
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2022.110320
– volume: 129
  start-page: 32
  issue: 1
  year: 1990
  ident: 1760_CR133
  publication-title: Cell Immuno
  doi: 10.1016/0008-8749(90)90184-S
– volume: 24
  start-page: 230
  issue: 2
  year: 2022
  ident: 1760_CR75
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-021-00820-9
– volume: 9
  start-page: e003149
  issue: 9
  year: 2021
  ident: 1760_CR308
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2021-003149
– volume: 33
  start-page: 1013
  issue: 5
  year: 2021
  ident: 1760_CR45
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2021.02.001
– volume: 9
  start-page: eadd6995
  issue: 5
  year: 2023
  ident: 1760_CR312
  publication-title: Sci Adv
  doi: 10.1126/sciadv.add6995
– volume: 46
  start-page: 233
  issue: 2
  year: 2017
  ident: 1760_CR228
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.01.005
– volume: 319
  start-page: 1902
  issue: 12
  year: 2013
  ident: 1760_CR65
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2013.04.005
– volume: 49
  start-page: 971
  issue: 5
  year: 2018
  ident: 1760_CR176
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.09.009
– volume: 79
  start-page: 324
  year: 2015
  ident: 1760_CR101
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2014.11.012
– volume: 21
  start-page: 555
  issue: 5
  year: 2020
  ident: 1760_CR153
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0666-9
– volume: 30
  start-page: 968
  issue: 6
  year: 2016
  ident: 1760_CR262
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.10.006
– volume: 15
  start-page: 47
  issue: 1
  year: 2012
  ident: 1760_CR28
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e32834de431
– volume: 17
  start-page: 61
  year: 2018
  ident: 1760_CR56
  publication-title: Mol Metabol
  doi: 10.1016/j.molmet.2018.08.002
– volume: 18
  start-page: 735
  issue: 5
  year: 2020
  ident: 1760_CR122
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-19-0018
– volume: 12
  start-page: 599
  issue: 8
  year: 2021
  ident: 1760_CR169
  publication-title: Protein Cell
  doi: 10.1007/s13238-020-00789-5
– volume: 13
  start-page: 6308
  issue: 1
  year: 2022
  ident: 1760_CR10
  publication-title: Nat Comm
  doi: 10.1038/s41467-022-34064-4
– volume: 11
  start-page: 2055703
  issue: 1
  year: 2022
  ident: 1760_CR328
  publication-title: Oncoimmunol
  doi: 10.1080/2162402X.2022.2055703
– volume: 184
  start-page: 4186
  issue: 16
  year: 2021
  ident: 1760_CR157
  publication-title: Cell
  doi: 10.1016/j.cell.2021.06.007
– volume: 101
  start-page: 811
  issue: 4
  year: 2017
  ident: 1760_CR186
  publication-title: J Leukocyte Biol
  doi: 10.1189/jlb.1HI0216-062RR
– volume: 15
  start-page: 623
  issue: 3
  year: 2023
  ident: 1760_CR316
  publication-title: Cancers
  doi: 10.3390/cancers15030623
– volume: 93
  start-page: 106051
  year: 2021
  ident: 1760_CR295
  publication-title: Int J Surg (London, England)
  doi: 10.1016/j.ijsu.2021.106051
– volume: 431
  start-page: 54
  year: 2018
  ident: 1760_CR233
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.05.005
– volume: 619
  start-page: 616
  issue: 7970
  year: 2023
  ident: 1760_CR193
  publication-title: Nature
  doi: 10.1038/s41586-023-06256-5
– volume: 143
  start-page: 103270
  year: 2021
  ident: 1760_CR181
  publication-title: J Reprod Immunol
  doi: 10.1016/j.jri.2020.103270
– volume: 44
  start-page: 100482
  issue: 1
  year: 2020
  ident: 1760_CR293
  publication-title: Curr Prob Cancer
  doi: 10.1016/j.currproblcancer.2019.05.005
– volume: 265
  start-page: 174
  issue: 1
  year: 2001
  ident: 1760_CR188
  publication-title: Exp Cell Res
  doi: 10.1006/excr.2001.5177
– volume: 65
  start-page: 10794
  issue: 23
  year: 2005
  ident: 1760_CR272
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-0623
– volume: 7
  start-page: 192
  issue: 1
  year: 2022
  ident: 1760_CR113
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-022-01017-8
– volume: 10
  start-page: 243
  issue: 3
  year: 2019
  ident: 1760_CR127
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1463-y
– volume: 42
  start-page: 112186
  issue: 3
  year: 2023
  ident: 1760_CR161
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2023.112186
– volume: 11
  start-page: 933
  issue: 4
  year: 2021
  ident: 1760_CR26
  publication-title: Cancer Disc
  doi: 10.1158/2159-8290.CD-20-1808
– volume: 4
  start-page: 93
  issue: 1
  year: 2018
  ident: 1760_CR171
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2017.1617
– volume: 42
  start-page: 291
  issue: 1
  year: 2023
  ident: 1760_CR324
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-023-02845-4
– volume: 17
  start-page: 2868
  issue: 3
  year: 2023
  ident: 1760_CR334
  publication-title: ACS Nano
  doi: 10.1021/acsnano.2c11280
– volume: 34
  start-page: 313
  issue: 3
  year: 2023
  ident: 1760_CR71
  publication-title: Rev Neurosci
  doi: 10.1515/revneuro-2022-0047
– volume: 159
  start-page: 1253
  issue: 6
  year: 2014
  ident: 1760_CR80
  publication-title: Cell
  doi: 10.1016/j.cell.2014.11.034
– volume: 292
  start-page: 121938
  year: 2023
  ident: 1760_CR338
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2022.121938
– volume: 147
  start-page: 335
  issue: 1
  year: 2021
  ident: 1760_CR173
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.04.037
– volume: 23
  start-page: 75
  issue: 1
  year: 2021
  ident: 1760_CR164
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-020-00615-4
– volume: 14
  start-page: 74
  year: 2016
  ident: 1760_CR273
  publication-title: EBioMed
  doi: 10.1016/j.ebiom.2016.11.013
– volume: 368
  start-page: eaaw5473
  issue: 6487
  year: 2020
  ident: 1760_CR2
  publication-title: Science (New York, NY)
  doi: 10.1126/science.aaw5473
– volume: 35
  start-page: 871
  issue: 6
  year: 2011
  ident: 1760_CR297
  publication-title: Immunity
  doi: 10.1016/j.immuni.2011.09.021
– volume: 39
  start-page: 3980
  issue: 20
  year: 2020
  ident: 1760_CR57
  publication-title: Oncogene
  doi: 10.1038/s41388-020-1262-z
– volume: 184
  start-page: 4168
  issue: 16
  year: 2021
  ident: 1760_CR174
  publication-title: Cell
  doi: 10.1016/j.cell.2021.05.045
– volume: 20
  start-page: 49
  issue: 1
  year: 2001
  ident: 1760_CR216
  publication-title: Amino Acids
  doi: 10.1007/s007260170065
– volume: 33
  start-page: 8711
  issue: 8
  year: 2019
  ident: 1760_CR41
  publication-title: FASEB J
  doi: 10.1096/fj.201802842RR
– volume: 25
  start-page: 404
  issue: 3
  year: 2023
  ident: 1760_CR91
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-023-01091-2
– volume: 34
  start-page: 337
  issue: 3
  year: 2008
  ident: 1760_CR215
  publication-title: Amino Acids
  doi: 10.1007/s00726-007-0560-x
– volume: 1861
  start-page: 3024
  issue: 11 Pt B
  year: 2017
  ident: 1760_CR27
  publication-title: Biochimica et biophysica acta General subjects
  doi: 10.1016/j.bbagen.2017.01.014
– volume: 8
  start-page: e44210
  year: 2019
  ident: 1760_CR129
  publication-title: Life
– volume: 18
  start-page: 1374
  issue: 8
  year: 2019
  ident: 1760_CR291
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-18-1323
– volume: 325
  start-page: C550
  issue: 2
  year: 2023
  ident: 1760_CR251
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00169.2023
– volume: 65
  start-page: 3699
  issue: 23
  year: 2008
  ident: 1760_CR6
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-008-8295-8
– volume: 42
  start-page: 419
  issue: 3
  year: 2015
  ident: 1760_CR201
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.02.005
– volume: 19
  start-page: 1423
  issue: 11
  year: 2013
  ident: 1760_CR18
  publication-title: Nat Med
  doi: 10.1038/nm.3394
– volume: 9
  start-page: 1864
  issue: 10
  year: 2023
  ident: 1760_CR330
  publication-title: ACS Cent Sci
  doi: 10.1021/acscentsci.3c00702
– volume: 280
  start-page: E75
  issue: 1
  year: 2001
  ident: 1760_CR270
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.2001.280.1.E75
– volume: 105
  start-page: 4127
  issue: 10
  year: 2005
  ident: 1760_CR142
  publication-title: Blood
  doi: 10.1182/blood-2004-05-1726
– volume: 117
  start-page: 2570
  issue: 9
  year: 2007
  ident: 1760_CR172
  publication-title: J Clin Invest
  doi: 10.1172/JCI31911
– volume: 14
  start-page: 3673
  issue: 1
  year: 2023
  ident: 1760_CR93
  publication-title: Nat Comm
  doi: 10.1038/s41467-023-39401-9
– volume: 164
  start-page: 3283
  issue: 6
  year: 2000
  ident: 1760_CR199
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.6.3283
– volume: 22
  start-page: 476
  issue: 4
  year: 2020
  ident: 1760_CR92
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-020-0496-x
– volume: 291
  start-page: 412
  issue: 3
  year: 2023
  ident: 1760_CR8
  publication-title: FEBS J
  doi: 10.1111/febs.16803
– volume: 313
  start-page: 443
  issue: 2
  year: 2004
  ident: 1760_CR42
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2003.07.019
– volume: 491
  start-page: 458
  issue: 7424
  year: 2012
  ident: 1760_CR84
  publication-title: Nature
  doi: 10.1038/nature11540
– volume: 10
  start-page: 20030
  issue: 1
  year: 2020
  ident: 1760_CR108
  publication-title: Sci Reports
– volume: 616
  start-page: 339
  issue: 7956
  year: 2023
  ident: 1760_CR315
  publication-title: Nature
  doi: 10.1038/s41586-023-05891-2
– volume: 373
  start-page: 37
  year: 2022
  ident: 1760_CR4
  publication-title: Int Rev Cell Mol Biol
  doi: 10.1016/bs.ircmb.2022.08.001
– volume: 20
  start-page: 436
  issue: 7
  year: 2019
  ident: 1760_CR35
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-019-0123-5
– volume: 25
  start-page: 345
  issue: 2
  year: 2017
  ident: 1760_CR160
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2016.12.011
– volume: 52
  start-page: 15
  issue: 1
  year: 2020
  ident: 1760_CR116
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-020-0375-3
– volume: 14
  start-page: 4677
  issue: 1
  year: 2023
  ident: 1760_CR234
  publication-title: Nat Comm
  doi: 10.1038/s41467-023-39571-6
– volume: S1525–0016
  start-page: 00319
  issue: 24
  year: 2024
  ident: 1760_CR327
  publication-title: Mol Ther
– volume: 34
  start-page: 363
  issue: 5
  year: 2023
  ident: 1760_CR319
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2023.08.002
– volume: 8
  start-page: 112
  issue: 5
  year: 2019
  ident: 1760_CR246
  publication-title: Antioxidants (Basel)
  doi: 10.3390/antiox8050112
– volume: 33
  start-page: 60
  issue: 1
  year: 2023
  ident: 1760_CR280
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2022.09.002
– volume: 8
  start-page: e45572
  year: 2019
  ident: 1760_CR250
  publication-title: Life
– volume: 18
  start-page: 985
  issue: 9
  year: 2017
  ident: 1760_CR202
  publication-title: Nat Immunol
  doi: 10.1038/ni.3796
– volume: 16
  start-page: 10742
  issue: 7
  year: 2022
  ident: 1760_CR336
  publication-title: ACS Nano
  doi: 10.1021/acsnano.2c02605
– volume: 29
  start-page: 3153
  issue: 21
  year: 2010
  ident: 1760_CR124
  publication-title: Oncogene
  doi: 10.1038/onc.2010.51
– volume: 4
  start-page: 100941
  issue: 2
  year: 2023
  ident: 1760_CR149
  publication-title: Cell Rep Med
  doi: 10.1016/j.xcrm.2023.100941
– volume: 18
  start-page: 49
  issue: 1
  year: 2006
  ident: 1760_CR190
  publication-title: Curr Opinion Immunol
  doi: 10.1016/j.coi.2005.11.008
– volume: 186
  start-page: 1846
  issue: 9
  year: 2023
  ident: 1760_CR148
  publication-title: Cell
  doi: 10.1016/j.cell.2023.03.011
– volume: 16
  start-page: 89
  issue: 2
  year: 2004
  ident: 1760_CR166
  publication-title: Sem Immunol
  doi: 10.1016/j.smim.2003.12.005
– volume: 173
  start-page: 117
  issue: 1
  year: 2018
  ident: 1760_CR256
  publication-title: Cell
  doi: 10.1016/j.cell.2018.03.001
– volume: 28
  start-page: 862
  issue: 2
  year: 2023
  ident: 1760_CR323
  publication-title: Molecules (Basel, Switzerland)
  doi: 10.3390/molecules28020862
– volume: 35
  start-page: 7
  year: 2016
  ident: 1760_CR294
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2016.03.002
– volume: 569
  start-page: 270
  issue: 7755
  year: 2019
  ident: 1760_CR135
  publication-title: Nature
  doi: 10.1038/s41586-019-1170-y
– volume: 84
  start-page: 102218
  year: 2023
  ident: 1760_CR285
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2023.102218
– volume: 7
  start-page: e36158
  year: 2018
  ident: 1760_CR138
  publication-title: eLife
  doi: 10.7554/eLife.36158
– volume: 11
  start-page: 616367
  year: 2020
  ident: 1760_CR236
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.616367
– volume: 10
  start-page: 4
  issue: 1
  year: 2012
  ident: 1760_CR267
  publication-title: Curr Vasc Pharmacol
  doi: 10.2174/157016112798829760
– volume: 81
  start-page: 2303
  issue: 11
  year: 2021
  ident: 1760_CR121
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2021.04.002
– volume: 30
  start-page: 414
  issue: 3
  year: 2019
  ident: 1760_CR257
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2019.08.011
– volume: 11
  start-page: 88
  issue: 2
  year: 2020
  ident: 1760_CR247
  publication-title: Cell Death Disease
  doi: 10.1038/s41419-020-2298-2
– volume: 42
  start-page: 1294
  issue: 16
  year: 2023
  ident: 1760_CR310
  publication-title: Oncogene
  doi: 10.1038/s41388-023-02632-7
– volume: 287
  start-page: 38210
  issue: 45
  year: 2012
  ident: 1760_CR94
  publication-title: The J Biol Chem
  doi: 10.1074/jbc.M112.392225
– volume: 13
  start-page: 1010
  issue: 11
  year: 2022
  ident: 1760_CR89
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-05448-7
– volume: 7
  start-page: 50
  issue: 7
  year: 2023
  ident: 1760_CR318
  publication-title: Cell Stress
  doi: 10.15698/cst2023.07.281
– volume: 20
  start-page: 6891
  issue: 47
  year: 2001
  ident: 1760_CR83
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204792
– volume: 13
  start-page: 3541
  issue: 14
  year: 2021
  ident: 1760_CR63
  publication-title: Cancers
  doi: 10.3390/cancers13143541
– volume: 16
  start-page: 420
  issue: 6
  year: 2006
  ident: 1760_CR95
  publication-title: Sem Cancer Biol
  doi: 10.1016/j.semcancer.2006.10.009
– volume: 9
  start-page: 2341
  issue: 1
  year: 2018
  ident: 1760_CR177
  publication-title: Nat Comm
  doi: 10.1038/s41467-018-04719-2
– volume: 115
  start-page: 5839
  issue: 23
  year: 2018
  ident: 1760_CR100
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1804932115
– volume: 11
  start-page: e0275922
  issue: 2
  year: 2023
  ident: 1760_CR322
  publication-title: Microbiol Spectrum
  doi: 10.1128/spectrum.02759-22
– volume: 29
  start-page: 885
  issue: 5
  year: 2019
  ident: 1760_CR184
  publication-title: Mod Rheumatol
  doi: 10.1080/14397595.2018.1510822
– volume: 23
  start-page: 270
  issue: 2
  year: 2016
  ident: 1760_CR249
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2015.93
– volume: 9
  start-page: 91
  issue: 2
  year: 2009
  ident: 1760_CR159
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2487
– volume: 15
  start-page: eadd7900
  issue: 705
  year: 2023
  ident: 1760_CR326
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.add7900
– volume: 11
  start-page: 1666
  issue: 11
  year: 2021
  ident: 1760_CR98
  publication-title: Biomolecules
  doi: 10.3390/biom11111666
– volume: 34
  start-page: 1280
  issue: 9
  year: 2022
  ident: 1760_CR187
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2022.08.008
– volume: 15
  start-page: 1243
  issue: 12
  year: 2014
  ident: 1760_CR287
  publication-title: EMBO Rep
  doi: 10.15252/embr.201439246
– volume: 48
  start-page: 491
  issue: 4
  year: 2012
  ident: 1760_CR107
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.11.006
– volume: 39
  start-page: e103334
  issue: 8
  year: 2020
  ident: 1760_CR292
  publication-title: EMBO J
  doi: 10.15252/embj.2019103334
– volume: 16
  start-page: 650
  issue: 10
  year: 2016
  ident: 1760_CR36
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.81
– volume: 13
  start-page: 1256769
  year: 2023
  ident: 1760_CR313
  publication-title: Front Oncol
  doi: 10.3389/fonc.2023.1256769
– volume: 31
  start-page: 250
  issue: 2
  year: 2020
  ident: 1760_CR131
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2020.01.006
– volume: 2
  start-page: 722
  issue: 8
  year: 2012
  ident: 1760_CR276
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-12-0014
– volume: 18
  start-page: 379
  issue: 5
  year: 2019
  ident: 1760_CR197
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-019-0016-5
– volume: 5
  start-page: 1423
  issue: 8
  year: 2023
  ident: 1760_CR165
  publication-title: Nat Metabol
  doi: 10.1038/s42255-023-00856-1
– volume: 20
  start-page: 597
  issue: 5
  year: 2018
  ident: 1760_CR252
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-018-0083-6
– volume: 16
  start-page: 278
  issue: 3
  year: 2020
  ident: 1760_CR245
  publication-title: Nat Chem Biol
  doi: 10.1038/s41589-019-0462-8
– volume: 47
  start-page: 349
  issue: 3
  year: 2012
  ident: 1760_CR43
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.05.043
– volume: 262
  start-page: 14366
  issue: 29
  year: 1987
  ident: 1760_CR82
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)47947-1
– volume: 5
  start-page: 641
  issue: 8
  year: 2005
  ident: 1760_CR231
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1668
– volume: 81
  start-page: 2076
  issue: 10
  year: 2021
  ident: 1760_CR105
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2021.03.009
– volume: 24
  start-page: 685
  issue: 5
  year: 2016
  ident: 1760_CR289
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2016.10.011
– volume: 4
  start-page: 1206
  issue: 12
  year: 2003
  ident: 1760_CR225
  publication-title: Nat Immunol
  doi: 10.1038/ni1003
– volume: 44
  start-page: 236
  issue: 3
  year: 2023
  ident: 1760_CR339
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A7762
– volume: 160
  start-page: 5347
  issue: 11
  year: 1998
  ident: 1760_CR206
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.11.5347
– volume: 12
  start-page: 30
  issue: 1
  year: 2011
  ident: 1760_CR51
  publication-title: Curr Protein Pept Sci
  doi: 10.2174/138920311795659407
– volume: 53
  start-page: 788
  issue: 5
  year: 2021
  ident: 1760_CR109
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-021-00613-y
– volume: 20
  start-page: 2779
  issue: 7
  year: 2024
  ident: 1760_CR182
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.95484
– volume: 21
  start-page: 683
  issue: 11
  year: 2020
  ident: 1760_CR192
  publication-title: Nat Rev Genet
  doi: 10.1038/s41576-020-0262-8
– volume: 42
  start-page: 3447
  issue: 47
  year: 2023
  ident: 1760_CR12
  publication-title: Oncogene
  doi: 10.1038/s41388-023-02868-3
– volume: 424
  start-page: 69
  issue: 1–2
  year: 2017
  ident: 1760_CR194
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-016-2843-6
– volume: 16
  start-page: 9
  issue: 1
  year: 2012
  ident: 1760_CR114
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2012.06.001
– volume: 61
  start-page: 102641
  year: 2023
  ident: 1760_CR111
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2023.102641
– volume: 562
  start-page: 423
  issue: 7727
  year: 2018
  ident: 1760_CR139
  publication-title: Nature
  doi: 10.1038/s41586-018-0597-x
– volume: 11
  start-page: 4397
  issue: 12
  year: 2023
  ident: 1760_CR321
  publication-title: Biomaterials Sci
  doi: 10.1039/D3BM90029K
– volume: 26
  start-page: 310
  issue: 2
  year: 2017
  ident: 1760_CR33
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2017.06.010
– volume: 190
  start-page: 3783
  issue: 7
  year: 2013
  ident: 1760_CR232
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201449
– volume: 42
  start-page: 52
  issue: 1
  year: 2023
  ident: 1760_CR180
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-023-02629-w
– volume: 19
  start-page: 405
  issue: 7
  year: 2019
  ident: 1760_CR241
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0149-1
– volume: 510
  start-page: 298
  issue: 7504
  year: 2014
  ident: 1760_CR96
  publication-title: Nature
  doi: 10.1038/nature13236
– volume: 184
  start-page: 1245
  issue: 5
  year: 2021
  ident: 1760_CR140
  publication-title: Cell
  doi: 10.1016/j.cell.2021.02.021
– volume: 11
  start-page: 109
  issue: 2
  year: 1978
  ident: 1760_CR34
  publication-title: J Mol Evol
  doi: 10.1007/BF01733887
– volume: 4
  start-page: 9
  issue: 1
  year: 2023
  ident: 1760_CR281
  publication-title: Nat Cancer
– volume: 48
  start-page: 681
  issue: 5
  year: 2012
  ident: 1760_CR300
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.09.017
– volume: 10
  start-page: e72593
  year: 2021
  ident: 1760_CR7
  publication-title: eLife
  doi: 10.7554/eLife.72593
– volume: 15
  start-page: 490
  issue: 5
  year: 2005
  ident: 1760_CR103
  publication-title: Curr Opin Genet Dev
  doi: 10.1016/j.gde.2005.08.002
– volume: 37
  start-page: 147
  issue: 2
  year: 2020
  ident: 1760_CR115
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.12.011
– ident: 1760_CR14
  doi: 10.3390/medicina56010015
– volume: 4
  start-page: eaar2606
  issue: 1
  year: 2018
  ident: 1760_CR66
  publication-title: Science advances
  doi: 10.1126/sciadv.aar2606
– volume: 105
  start-page: 110
  issue: 1
  year: 1987
  ident: 1760_CR156
  publication-title: Cell Immunol
  doi: 10.1016/0008-8749(87)90060-8
– volume: 13
  start-page: 925
  issue: 11
  year: 2022
  ident: 1760_CR238
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-05384-6
– volume: 14
  start-page: 500
  issue: 5
  year: 2013
  ident: 1760_CR163
  publication-title: Nat Immunol
  doi: 10.1038/ni.2556
– volume: 56
  start-page: 1833
  issue: 13
  year: 2021
  ident: 1760_CR278
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2021.05.011
– volume: 40
  start-page: 692
  issue: 5
  year: 2014
  ident: 1760_CR141
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.04.007
– volume: 40
  start-page: 4
  issue: 1
  year: 2019
  ident: 1760_CR244
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2018.10.008
– volume: 17
  start-page: 1583
  issue: 2
  year: 2023
  ident: 1760_CR337
  publication-title: ACS Nano
  doi: 10.1021/acsnano.2c11037
– volume: 15
  start-page: 123
  year: 2020
  ident: 1760_CR191
  publication-title: Ann Rev Pathol
  doi: 10.1146/annurev-pathmechdis-012418-012718
– volume: 64
  start-page: 693
  issue: 5
  year: 2023
  ident: 1760_CR340
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.122.264859
– volume: 84
  start-page: 538
  issue: 3
  year: 2024
  ident: 1760_CR119
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2023.11.042
– volume: 75
  start-page: 1147
  issue: 6
  year: 2019
  ident: 1760_CR196
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2019.06.039
– volume: 84
  start-page: 744
  issue: 4
  year: 2024
  ident: 1760_CR212
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2024.01.002
– volume: 70
  start-page: 68
  issue: 1
  year: 2010
  ident: 1760_CR134
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-2587
– volume: 170
  start-page: 19
  year: 2021
  ident: 1760_CR104
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2020.12.002
– volume: 76
  start-page: 2125
  issue: 8
  year: 2016
  ident: 1760_CR226
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1490
– volume: 33
  start-page: 1236
  issue: 17–18
  year: 2019
  ident: 1760_CR74
  publication-title: Genes Dev
  doi: 10.1101/gad.327056.119
– volume: 199
  start-page: 1967
  issue: 6
  year: 2017
  ident: 1760_CR301
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700497
– volume: 358
  start-page: 813
  issue: 6364
  year: 2017
  ident: 1760_CR44
  publication-title: Sci (New York, NY)
  doi: 10.1126/science.aao3265
– volume: 7
  start-page: eabe2771
  issue: 9
  year: 2021
  ident: 1760_CR126
  publication-title: Science Adv
  doi: 10.1126/sciadv.abe2771
– volume: 109
  start-page: 3737
  issue: 12
  year: 2018
  ident: 1760_CR286
  publication-title: Cancer Sci
  doi: 10.1111/cas.13827
– volume: 52
  start-page: 1496
  issue: 9
  year: 2020
  ident: 1760_CR60
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-020-00504-8
– volume: 20
  start-page: 7
  issue: 1
  year: 2020
  ident: 1760_CR221
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0210-z
– volume: 353
  start-page: 104119
  year: 2020
  ident: 1760_CR25
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2020.104119
– volume: 3
  start-page: 1313
  issue: 10
  year: 2021
  ident: 1760_CR203
  publication-title: Nat Metabol
  doi: 10.1038/s42255-021-00471-y
– volume: 19
  start-page: 102
  issue: 2
  year: 2023
  ident: 1760_CR311
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-022-00648-y
– volume: 559
  start-page: 216120
  year: 2023
  ident: 1760_CR317
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2023.216120
– volume: 18
  start-page: 681
  issue: 11
  year: 2018
  ident: 1760_CR64
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0050-3
– volume: 7
  start-page: 14749
  issue: 1
  year: 2017
  ident: 1760_CR265
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-15246-3
– volume: 39
  start-page: 204
  issue: 1
  year: 2020
  ident: 1760_CR21
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-020-01709-5
– volume: 13
  start-page: 2698
  issue: 1
  year: 2022
  ident: 1760_CR40
  publication-title: Nat Comm
  doi: 10.1038/s41467-022-30362-z
– volume: 72
  start-page: 501
  issue: 3
  year: 2023
  ident: 1760_CR106
  publication-title: Gut
  doi: 10.1136/gutjnl-2022-326928
– volume: 410
  start-page: 608
  issue: 6828
  year: 2001
  ident: 1760_CR222
  publication-title: Nature
  doi: 10.1038/35069118
– volume: 13
  start-page: 988295
  year: 2022
  ident: 1760_CR290
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2022.988295
– volume: 134
  start-page: 489
  issue: 3
  year: 2004
  ident: 1760_CR86
  publication-title: J Nutr
  doi: 10.1093/jn/134.3.489
– volume: 596
  start-page: 281
  issue: 7871
  year: 2021
  ident: 1760_CR48
  publication-title: Nature
  doi: 10.1038/s41586-021-03768-w
– volume: 4
  start-page: 458
  issue: 4
  year: 2022
  ident: 1760_CR39
  publication-title: Nat Metabol
  doi: 10.1038/s42255-022-00558-0
– volume: 187
  start-page: 1422
  issue: 6
  year: 2024
  ident: 1760_CR214
  publication-title: Cell
  doi: 10.1016/j.cell.2024.02.005
– volume: 210
  start-page: 383
  issue: 3
  year: 2014
  ident: 1760_CR144
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu115
– volume: 277
  start-page: 21123
  issue: 24
  year: 2002
  ident: 1760_CR152
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110675200
– volume: 8
  start-page: 32
  issue: 1
  year: 2020
  ident: 1760_CR307
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-19-0041
– volume: 563
  start-page: 564
  issue: 7732
  year: 2018
  ident: 1760_CR309
  publication-title: Nature
  doi: 10.1038/s41586-018-0701-2
– volume: 16
  start-page: 508
  issue: 3
  year: 2018
  ident: 1760_CR125
  publication-title: J Thrombosis Haemostasis
  doi: 10.1111/jth.13951
– volume: 35
  start-page: 118
  issue: 1
  year: 2023
  ident: 1760_CR22
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2022.12.003
– volume: 99
  start-page: 464
  issue: 3
  year: 2008
  ident: 1760_CR88
  publication-title: Brit J Cancer
  doi: 10.1038/sj.bjc.6604485
– volume: 27
  start-page: 393
  issue: 2
  year: 2018
  ident: 1760_CR185
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2017.12.007
– volume: 620
  start-page: 200
  issue: 7972
  year: 2023
  ident: 1760_CR224
  publication-title: Nature
  doi: 10.1038/s41586-023-06299-8
– volume: 7
  start-page: 610
  issue: 1
  year: 2016
  ident: 1760_CR77
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6311
– volume: 8
  start-page: e001532
  issue: 2
  year: 2020
  ident: 1760_CR306
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2020-001532
– volume: 16
  start-page: 619
  issue: 10
  year: 2016
  ident: 1760_CR78
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.71
– volume: 31
  start-page: 920
  issue: 5
  year: 2020
  ident: 1760_CR170
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2020.03.004
– volume: 12
  start-page: 18691
  issue: 18
  year: 2023
  ident: 1760_CR72
  publication-title: Cancer Med
  doi: 10.1002/cam4.6484
– volume: 13
  start-page: 2394
  issue: 9
  year: 2023
  ident: 1760_CR331
  publication-title: Drug Deliv Transl Res
  doi: 10.1007/s13346-023-01323-w
– volume: 28
  start-page: 655
  issue: 6
  year: 2018
  ident: 1760_CR58
  publication-title: Cell Res
  doi: 10.1038/s41422-018-0021-y
– volume: 39
  start-page: 191
  issue: 4
  year: 2014
  ident: 1760_CR69
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2014.02.004
– volume: 3
  start-page: 676
  year: 2012
  ident: 1760_CR123
  publication-title: Nat Comm
  doi: 10.1038/ncomms1676
– volume: 5
  start-page: e202201663
  issue: 12
  year: 2022
  ident: 1760_CR168
  publication-title: Life Sci Alliance
  doi: 10.26508/lsa.202201663
– volume: 224
  start-page: 113232
  year: 2023
  ident: 1760_CR333
  publication-title: Colloids Surf B Biointerfaces
  doi: 10.1016/j.colsurfb.2023.113232
– volume: 14
  start-page: 1133308
  year: 2023
  ident: 1760_CR19
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2023.1133308
– volume: 116
  start-page: 12452
  issue: 25
  year: 2019
  ident: 1760_CR299
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1818521116
– volume: 2
  start-page: 251
  issue: 4
  year: 2002
  ident: 1760_CR128
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri778
– volume: 26
  start-page: 2339
  issue: 12
  year: 2008
  ident: 1760_CR263
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328312c8a3
– volume: 168
  start-page: 960
  issue: 6
  year: 2017
  ident: 1760_CR50
  publication-title: Cell
  doi: 10.1016/j.cell.2017.02.004
– volume: 3
  start-page: 983
  issue: 7
  year: 2021
  ident: 1760_CR118
  publication-title: Nat Metabol
  doi: 10.1038/s42255-021-00412-9
– volume: 54
  start-page: 2354
  issue: 10
  year: 2021
  ident: 1760_CR227
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.09.005
– volume: 16
  start-page: 59
  issue: 1
  year: 2023
  ident: 1760_CR204
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-023-01453-1
– volume: 19
  start-page: 369
  issue: 6
  year: 2019
  ident: 1760_CR24
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0127-6
– volume: 294
  start-page: 4644
  issue: 12
  year: 2019
  ident: 1760_CR178
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA118.005892
– volume: 29
  start-page: 1003
  issue: 4
  year: 2019
  ident: 1760_CR210
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2019.01.014
– volume: 184
  start-page: 2680
  issue: 10
  year: 2021
  ident: 1760_CR102
  publication-title: Cell
  doi: 10.1016/j.cell.2021.04.001
– volume: 50
  start-page: 353
  issue: 2
  year: 2001
  ident: 1760_CR49
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.2.353
– volume: 92
  start-page: 102066
  year: 2023
  ident: 1760_CR85
  publication-title: Ageing Res Rev
  doi: 10.1016/j.arr.2023.102066
– volume: 74
  start-page: 2170
  issue: 4
  year: 2021
  ident: 1760_CR179
  publication-title: Hepatol (Baltimore, Md)
  doi: 10.1002/hep.31875
– volume: 7
  start-page: 246
  issue: 1
  year: 2019
  ident: 1760_CR302
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0725-7
– volume: 9
  start-page: 514
  issue: 5
  year: 2021
  ident: 1760_CR275
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-20-0226
– volume: 386
  start-page: 671
  issue: 6626
  year: 1997
  ident: 1760_CR255
  publication-title: Nature
  doi: 10.1038/386671a0
– volume: 29
  start-page: 124
  issue: 1
  year: 2019
  ident: 1760_CR283
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2018.09.012
– volume: 16
  start-page: 117864692311851
  year: 2023
  ident: 1760_CR314
  publication-title: Int J Tryptophan Res
  doi: 10.1177/11786469231185102
– volume: 23
  start-page: 27
  issue: 1
  year: 2016
  ident: 1760_CR1
  publication-title: Cell metabolism
  doi: 10.1016/j.cmet.2015.12.006
– volume: 178
  start-page: 93
  issue: 1
  year: 2007
  ident: 1760_CR61
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200703099
– volume: 259
  start-page: 171
  issue: 1
  year: 2014
  ident: 1760_CR150
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31828611f8
– volume: 36
  start-page: 2321
  issue: 16
  year: 2017
  ident: 1760_CR259
  publication-title: EMBO J
  doi: 10.15252/embj.201796436
– volume: 81
  start-page: 139
  year: 2019
  ident: 1760_CR29
  publication-title: Ann Rev Physiol
  doi: 10.1146/annurev-physiol-020518-114455
– volume: 83
  start-page: 2358
  issue: 14
  year: 2023
  ident: 1760_CR147
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-22-3042
– volume: 35
  start-page: e2211370
  issue: 23
  year: 2023
  ident: 1760_CR183
  publication-title: Adv Mater
  doi: 10.1002/adma.202211370
– volume: 14
  start-page: 165
  issue: 3
  year: 2023
  ident: 1760_CR112
  publication-title: Prot Cell
– volume: 21
  start-page: 1413
  issue: 11
  year: 2019
  ident: 1760_CR303
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-019-0408-0
– volume: 17
  start-page: 712
  issue: 6
  year: 2016
  ident: 1760_CR137
  publication-title: Nat Immunol
  doi: 10.1038/ni.3439
– volume: 46
  start-page: 92
  issue: 1
  year: 2016
  ident: 1760_CR151
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201546047
– volume: 20
  start-page: 50
  issue: 1
  year: 2019
  ident: 1760_CR198
  publication-title: Nat Immunol
  doi: 10.1038/s41590-018-0255-3
– volume: 35
  start-page: 109235
  issue: 11
  year: 2021
  ident: 1760_CR240
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2021.109235
– volume: 22
  start-page: e51239
  issue: 2
  year: 2021
  ident: 1760_CR253
  publication-title: EMBO Rep
  doi: 10.15252/embr.202051239
– volume: 10
  start-page: 614230
  year: 2020
  ident: 1760_CR282
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.614230
– volume: 31
  start-page: 24
  issue: 1
  year: 2021
  ident: 1760_CR146
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2020.09.010
– volume: 67
  start-page: 425
  issue: 1
  year: 2007
  ident: 1760_CR229
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-3037
– volume: 11
  start-page: 1866
  year: 2020
  ident: 1760_CR209
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.01866
– volume: 156
  start-page: 317
  issue: 1–2
  year: 2014
  ident: 1760_CR248
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.010
– volume: 164
  start-page: 376
  issue: 3
  year: 2023
  ident: 1760_CR53
  publication-title: Gastroenterol
  doi: 10.1053/j.gastro.2022.11.014
– volume: 2
  start-page: 1373
  issue: 12
  year: 2020
  ident: 1760_CR99
  publication-title: Nat Metabol
  doi: 10.1038/s42255-020-00315-1
– volume: 221
  start-page: 107746
  year: 2021
  ident: 1760_CR305
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2020.107746
SSID ssj0024547
Score 2.5077329
SecondaryResourceType review_article
Snippet Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming of amino...
Abstract Amino acid metabolism plays a pivotal role in tumor microenvironment, influencing various aspects of cancer progression. The metabolic reprogramming...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 380
SubjectTerms Adenosine
Amino acid metabolism
Amino acids
Amino Acids - metabolism
Analysis
Angiogenesis
Animals
Apoptosis
Biology
Biosynthesis
Cancer
Cancer therapies
Carbon
Care and treatment
Cell growth
Cellular Reprogramming
Colorectal cancer
Dehydrogenases
Development and progression
Diagnosis
Drug resistance
Enzymes
Epigenetic inheritance
Epigenetic regulation
Epigenetics
Extracellular matrix
Health aspects
Homeostasis
Humans
Immune response
Immune tolerance
Immunological tolerance
Immunomodulation
Kinases
Medical prognosis
Metabolic Reprogramming
Metabolism
Metabolites
Metastases
Metastasis
Neoplasms - metabolism
Neoplasms - pathology
Nitrogen
Oxidative metabolism
Oxidative stress
Phosphorylation
Physiological aspects
Polyamines
Protein biosynthesis
Protein synthesis
Protein turnover
Proteins
Redox
Review
Stromal cells
Tumor cells
Tumor Microenvironment
Tumors
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journal (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9VAEF-kIHgRtX6kVtmK4EFCk_3K7rFqS_XgQS30tmz2owbaRPreO_jfO7NJHi8Ieukt7E5C9jezmRky-xtC3rLghOIB0tTI2lIwuHLR5V4vjrXBCxEy2-dXdX4hvlzKy51WX1gTNtIDj8Adm6aS6MewMbLwyjkTdPDgmZKukouZbBt83pxMzSx7UjTzERmtjlc1_l0sYRxS50ZVZb1wQ5mt_-9v8o5TWhZM7nigs0fk4RQ60pPxlR-Te7F_Qu6PzSR_75NPoHGK5RhY_AN4USwcpEOi7qbrB-p8F-hNXIPSrztPkcwyV2bB5BXteupR_bdPycXZ6Y-P5-XUI6H00uh1GQM3XCGmrJEyMa6iMTK4yrVCON3EqCFd5qEKvDW1NqkF9xS9qVJwgFvgz8heP_TxBaEmwfp4AtOCpDFK4RI8KxkflGG-qU1B6hky6ycCcexjcW1zIqGVHWG2ALPNMNu6IO-39_wa6TP-Kf0BNbGVROrrPAAGYSeDsP8ziIK8QT1aJLfosXrmym1WK_v5-zd7oitmIAI1oiDvJqE0wBq8mw4jABLIh7WQPFxIwu7zy-nZXOy0-1eWg0FCGNUYwOxoO413YkVbH4cNymiptFIVL8jz0bq26-amUgZCz4Lohd0tgFnO9N3PzA0O4bOWgrGDu4DyJXnA8p5pSmYOyd76dhNfQQy2bl_n7fYH_SAryw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection (ProQuest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gIIOQOKCoie04nhMqj6pw4ABU6s1y_Niu1CZlHwf-PTPe7LYRUm9RPInimbFnJvnyDWPvRHBKy4BlahRdqQQeuehyrxcnuuCVCpnt84c-PlHfT5vT8YXbcoRVbvfEvFGHwdM78gOJgQ1DUwvw8fJPSV2j6Ovq2ELjNrtD1GUE6WpPrwouIqva_ihj9MGypm-MJZ7HArrVVVlPglHm7P9_Z74WmqawyWtx6OgBuz8mkPxwY_GH7FbsH7G7m5aSfx-zL2h3TqAMggCh1jjBB_mQuLuY9wN3fh74RVyh6c_nnhOlZcZn4eCMz3vuyQkWT9jJ0dffn4_LsVNC6RswqzIGCVKTZkXbNElIHQGa4CrXKeVMG6PBolmGKsgOagOpwyAVPVQpOFFBkE_ZXj_08TnjkHB-MqGDYekYG-US3iuBDxqEb2soWL1VmfUjjTh1szi3uZww2m7UbFHNNqvZ1gX7sLvmckOicaP0J7LETpIIsPOJYTGz43qy0FYNpTfUL1t57RwEEzwmLMlUyUVdsLdkR0sUFz1haGZuvVzab79-2kNTCcA8FFTB3o9CacA5eDf-koCaIFasieT-RBLXoJ8Ob93FjnvA0l55bMHe7IbpSsK19XFYk4xptNG6kgV7tvGu3bwlVBowAS2YmfjdRDHTkX5-lhnCMYk2jRLixc3P9ZLdE3k1tKWAfba3WqzjK8yxVt3rvJD-ASV9JA4
  priority: 102
  providerName: ProQuest
Title The significant role of amino acid metabolic reprogramming in cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/39069612
https://www.proquest.com/docview/3091293799
https://www.proquest.com/docview/3085686603
https://pubmed.ncbi.nlm.nih.gov/PMC11285422
https://doaj.org/article/9705007840824c6aa9d8dc021f80fae6
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9NAEF_OOwRfxG-jZ1lF8EGiye5ms_sgctU7TsFDqoXiy7LZjxroJdoP8P57Z7dJveBxL6V0JyH7y0znN-3kNwi9JFYzTi2UqY5UKSPwTjsdZ71oUlnDmI1qn2f8dMo-z4rZHurHHXUArq4s7cI8qely8ebP74v3EPDvYsAL_naVh_8OU8g2UBiXPEuhGjqAzFSGQP3CxD_tvSIOHMsZVE4iz2f9QzRXnmOQqKKe___f2pfS1rCl8lKOOrmDbnfkEh9tveEu2nPNPXRzO27y4j76CD6BQ8NGaA8CRHFoLcStx_q8blqsTW3xuVuDWyxqg4PcZezdgsU5rhtsgoMsH6DpyfH3D6dpN0UhNYUU69RZKikPqJOyKDyh3ElZWJ3pijEtSucEFNTUZpZWMhfSV5DAnJGZt5pk0tKHaL9pG_cYYelhf9SD80FZ6QqmPZzLS2O5JKbMZYLyHjJlOonxMOlioWKpIbjawqwAZhVhVnmCXu-O-bUV2LjWehzuxM4yiGPHD9rlXHWxpmSZFYH6hFnazHCtpRXWAJnxIvPa8QS9CPdRBfmLJvTXzPVmtVKfvk3UkciIBI4qWYJedUa-hT0Y3T2uAEgExayB5eHAEuLTDJd7d1G9eysKNA2IVikBs-e75XBk6HlrXLsJNqLggvOMJujR1rt2-6Yy4xLIaYLEwO8GwAxXmvpnVA8Hgi0KRsiT6y_7KbpFYjSUKZGHaH-93LhnwL_W1QjdKGflCB2Mj8--TkbxV4xRDDR4nYx__AURay1i
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiDeBAgaBOKCoie049gGhlrbapWWFSiv1Zhw_lpXapOxDqH-K38g4j20jpN56W8WTKB5_45nZjL9B6B2xmnFqIU11pIgZgV_a6brXiyaFNYzZmu1zzIfH7OtJdrKG_nZnYUJZZbcn1hu1rUz4j3yTgmMD15RL-fn8dxy6RoWvq10LjQYW--7iD6Rs80-jHVjf94Ts7R59GcZtV4HYZFIsYmeppDy8BcmzzBPKnZSZ1YkuGNMid05AgkltYmkhUyF9ARu6MzLxVpNEWgrPvYXWGYVUZoDWt3fH3w8v2f0ylndHcwTfnKfhq2YM1yFlz3kSpz33V3cJ-N8XXHGG_ULNK55v7z6614aseKvB2AO05sqH6HbTxPLiEdoBpOFQBhKKjmCdcChYxJXH-mxaVlibqcVnbgFgO50aHEg064owGJzgaYlNgN3sMTq-ES0-QYOyKt0zhKWH-VEPkIZk1WVMe3iWl8ZySUyeygilncqUaYnLQ_-MU1UnMIKrRs0K1KxqNas0Qh9X95w3tB3XSm-HlVhJBsrt-kI1m6jWgpXMkywEVKFDNzNca2mFNRAieZF47XiE3oZ1VIFUowxVOxO9nM_V6Meh2hIJkRD5ShahD62Qr2AORreHIEATgYerJ7nRkwSrN_3hDi6q3XXm6tJGIvRmNRzuDJV0pauWQUZkXHCe0Ag9bdC1mjeVCZcQ8kZI9HDXU0x_pJz-qjnJIWwXGSPk-fXv9RrdGR59O1AHo_H-C3SX1JaRx0RuoMFitnQvIcJbFK9as8Lo501b8j9MeWMF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+significant+role+of+amino+acid+metabolic+reprogramming+in+cancer&rft.jtitle=Cell+communication+and+signaling&rft.au=Liu%2C+Xiaohong&rft.au=Ren%2C+Bo&rft.au=Ren%2C+Jie&rft.au=Gu%2C+Minzhi&rft.date=2024-07-29&rft.pub=BioMed+Central+Ltd&rft.issn=1478-811X&rft.eissn=1478-811X&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12964-024-01760-1&rft.externalDocID=A802941694
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-811X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-811X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-811X&client=summon